<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1231" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1231/" /><meta name="ncbi_pagename" content="Isolated Methylmalonic Acidemia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Isolated Methylmalonic Acidemia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Isolated Methylmalonic Acidemia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/12/01" /><meta name="citation_author" content="Irini Manoli" /><meta name="citation_author" content="Jennifer L Sloan" /><meta name="citation_author" content="Charles P Venditti" /><meta name="citation_pmid" content="20301409" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1231/" /><meta name="citation_keywords" content="Isolated Methylmalonic Aciduria" /><meta name="citation_keywords" content="Isolated Methylmalonic Aciduria" /><meta name="citation_keywords" content="Deficiency of the Enzyme Methylmalonyl-Coa Epimerase" /><meta name="citation_keywords" content="Complete or Partial Deficiency of the Enzyme Methylmalonyl-Coa Mutase" /><meta name="citation_keywords" content="Defect in Transport or Synthesis of the Methylmalonyl-Coa Mutase Cofactor, Adenosyl-Cobalamin" /><meta name="citation_keywords" content="Corrinoid adenosyltransferase" /><meta name="citation_keywords" content="Methylmalonic aciduria and homocystinuria type D protein, mitochondrial" /><meta name="citation_keywords" content="Methylmalonic aciduria type A protein, mitochondrial" /><meta name="citation_keywords" content="Methylmalonyl-CoA epimerase, mitochondrial" /><meta name="citation_keywords" content="Methylmalonyl-CoA mutase, mitochondrial" /><meta name="citation_keywords" content="MCEE" /><meta name="citation_keywords" content="MMAA" /><meta name="citation_keywords" content="MMAB" /><meta name="citation_keywords" content="MMADHC" /><meta name="citation_keywords" content="MMUT" /><meta name="citation_keywords" content="Isolated Methylmalonic Acidemia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Isolated Methylmalonic Acidemia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Irini Manoli" /><meta name="DC.Contributor" content="Jennifer L Sloan" /><meta name="DC.Contributor" content="Charles P Venditti" /><meta name="DC.Date" content="2016/12/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1231/" /><meta name="description" content="Isolated methylmalonic acidemia/aciduria, the topic of this GeneReview, is caused by complete or partial deficiency of the enzyme methylmalonyl-CoA mutase (mut0 enzymatic subtype or mut– enzymatic subtype, respectively), a defect in the transport or synthesis of its cofactor, adenosyl-cobalamin (cblA, cblB, or cblD-MMA), or deficiency of the enzyme methylmalonyl-CoA epimerase. Onset of the manifestations of isolated methylmalonic acidemia/aciduria ranges from the neonatal period to adulthood. All phenotypes are characterized by periods of relative health and intermittent metabolic decompensation, usually associated with intercurrent infections and stress." /><meta name="og:title" content="Isolated Methylmalonic Acidemia" /><meta name="og:type" content="book" /><meta name="og:description" content="Isolated methylmalonic acidemia/aciduria, the topic of this GeneReview, is caused by complete or partial deficiency of the enzyme methylmalonyl-CoA mutase (mut0 enzymatic subtype or mut– enzymatic subtype, respectively), a defect in the transport or synthesis of its cofactor, adenosyl-cobalamin (cblA, cblB, or cblD-MMA), or deficiency of the enzyme methylmalonyl-CoA epimerase. Onset of the manifestations of isolated methylmalonic acidemia/aciduria ranges from the neonatal period to adulthood. All phenotypes are characterized by periods of relative health and intermittent metabolic decompensation, usually associated with intercurrent infections and stress." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1231/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mma/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1231/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88F16AE03FE8E100000000058E01C4.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1231_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1231_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kms/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/iso-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1231_"><span class="title" itemprop="name">Isolated Methylmalonic Acidemia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Isolated Methylmalonic Aciduria</div><p class="contrib-group"><span itemprop="author">Irini Manoli</span>, MD, PhD, <span itemprop="author">Jennifer L Sloan</span>, PhD, and <span itemprop="author">Charles P Venditti</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1231_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1231_ai__"><div class="contrib half_rhythm"><span itemprop="author">Irini Manoli</span>, MD, PhD<div class="affiliation small">Genetics and Molecular Biology Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@iilonam" class="oemail">vog.hin.liam@iilonam</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jennifer L Sloan</span>, PhD<div class="affiliation small">Genetics and Molecular Biology Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@naolsj" class="oemail">vog.hin.liam@naolsj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Charles P Venditti</span>, MD, PhD<div class="affiliation small">Genetics and Molecular Biology Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@ittidnev" class="oemail">vog.hin.liam@ittidnev</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 16, 2005</span>; Last Revision: <span itemprop="dateModified">December 1, 2016</span>.</p><p><em>Estimated reading time: 56 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mma.Summary" itemprop="description"><h2 id="_mma_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Isolated methylmalonic acidemia/aciduria, the topic of this <i>GeneReview</i>, is caused by complete or partial deficiency of the enzyme methylmalonyl-CoA mutase (<i>mut</i><sup>0</sup> enzymatic subtype or <i>mut</i><sup>&#x02013;</sup> enzymatic subtype, respectively), a defect in the transport or synthesis of its cofactor, adenosyl-cobalamin (<i>cblA</i>, <i>cblB</i>, or <i>cblD</i>-MMA), or deficiency of the enzyme methylmalonyl-CoA epimerase. Onset of the manifestations of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia/aciduria ranges from the neonatal period to adulthood. All phenotypes are characterized by periods of relative health and intermittent metabolic decompensation, usually associated with intercurrent infections and stress.</p><ul><li class="half_rhythm"><div>In the neonatal period the disease can present with lethargy, vomiting, hypotonia, hypothermia, respiratory distress, severe ketoacidosis, hyperammonemia, neutropenia, and thrombocytopenia and can result in death within the first four weeks of life.</div></li><li class="half_rhythm"><div>In the infantile/non-B<sub>12</sub>-responsive <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, infants are normal at birth, but develop lethargy, vomiting, dehydration, failure to thrive, hepatomegaly, hypotonia, and encephalopathy within a few weeks to months of age.</div></li><li class="half_rhythm"><div>An intermediate B<sub>12</sub>-responsive <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can occasionally be observed in neonates, but is usually observed in the first months or years of life; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children exhibit anorexia, failure to thrive, hypotonia, and developmental delay, and sometimes have protein aversion and/or vomiting and lethargy after protein intake.</div></li><li class="half_rhythm"><div>Atypical and "benign"/adult methylmalonic acidemia phenotypes are associated with increased, albeit mild, urinary excretion of methylmalonate.</div></li></ul><p>Major secondary complications of methylmalonic acidemia include: intellectual impairment (variable); tubulointerstitial nephritis with progressive renal failure; "metabolic stroke" (acute and chronic basal ganglia injury) causing a disabling movement disorder with choreoathetosis, dystonia, and para/quadriparesis; pancreatitis; growth failure; functional immune impairment; and optic nerve atrophy.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia relies on analysis of organic acids in plasma and/or urine by gas-liquid chromatography and mass spectrometry. Establishing the specific subtype of methylmalonic acidemia requires cellular biochemical studies (including <sup>14</sup>C propionate incorporation and B<sub>12</sub> responsiveness, complementation analysis, and cobalamin distribution assays) and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. The finding of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the five genes (<i>MMUT</i>, <i>MMAA</i>, <i>MMAB</i>, <i>MCEE</i>, and <i>MMADHC</i>) associated with isolated methylmalonic acidemia &#x02013; with confirmation of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status in the parents &#x02013; can establish the diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Critically ill individuals are stabilized by restoring volume status and acid-base balance; reducing or eliminating protein intake; providing increased calories via high glucose-containing fluids and insulin to arrest catabolism; and monitoring serum electrolytes and ammonia, venous or arterial blood gases, and urine output. Management includes a high-calorie diet low in propiogenic amino acid precursors; hydroxocobalamin intramuscular injections; carnitine supplementation; antibiotics such as neomycin or metronidazole to reduce propionate production from gut flora; gastrostomy tube placement as needed; and aggressive treatment of infections. Other therapies used in a limited number of patients include <i>N</i>-carbamylglutamate for the treatment of acute hyperammonemic episodes; liver, kidney, or combined liver and kidney transplantation; and antioxidants for the treatment of optic nerve atrophy.</p><p><i>Prevention of primary manifestations:</i> In some cases, <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> allows for presymptomatic detection of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> newborns and early treatment.</p><p><i>Agents/circumstances to avoid:</i> Fasting and increased dietary protein.</p><p><i>Other:</i> Medic Alert<sup>&#x000ae;</sup> bracelets and up-to-date, easily accessed, detailed emergency treatment protocols facilitate care.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Isolated methylmalonic acidemia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible using molecular genetic techniques if the pathogenic variants in the family are known. In some circumstances, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk is possible by enzyme analysis and metabolite measurements on cultured fetal cells (obtained by chorionic villus sampling or amniocentesis).</p></div></div><div id="mma.GeneReview_Scope"><h2 id="_mma_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="mma.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.Td_lrgtbl__"><table><thead><tr><th id="hd_h_mma.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isolated Methylmalonic Acidemia/Aciduria: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_mma.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Complete or partial deficiency of the enzyme methylmalonyl-CoA mutase</div></li><li class="half_rhythm"><div>Defect in transport or synthesis of the methylmalonyl-CoA mutase cofactor, adenosyl-cobalamin</div></li><li class="half_rhythm"><div>Deficiency of the enzyme methylmalonyl-CoA epimerase</div></li></ul>
</td></tr></tbody></table></div></div></div><div id="mma.Diagnosis"><h2 id="_mma_Diagnosis_">Diagnosis</h2><p>For this review, the term "<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia" refers to a group of inborn errors of metabolism associated with elevated methylmalonic acid (MMA) concentration in the blood and urine that result from the failure to convert methylmalonyl-CoA into succinyl-CoA during propionyl-CoA metabolism in the mitochondrial matrix, without hyperhomocysteinemia or homocystinuria, hypomethioninemia, or variations in other metabolites, such as malonic acid (<a class="figpopup" href="/books/NBK1231/figure/mma.F1/?report=objectonly" target="object" rid-figpopup="figmmaF1" rid-ob="figobmmaF1">Figure 1</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmmaF1" co-legend-rid="figlgndmmaF1"><a href="/books/NBK1231/figure/mma.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figmmaF1" rid-ob="figobmmaF1"><img class="small-thumb" src="/books/NBK1231/bin/mma-Image001.gif" src-large="/books/NBK1231/bin/mma-Image001.jpg" alt="Figure 1. . Major pathway of the conversion of propionyl-CoA into succinyl-CoA." /></a><div class="icnblk_cntnt" id="figlgndmmaF1"><h4 id="mma.F1"><a href="/books/NBK1231/figure/mma.F1/?report=objectonly" target="object" rid-ob="figobmmaF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Major pathway of the conversion of propionyl-CoA into succinyl-CoA. The biotin-dependent enzyme propionyl-CoA carboxylase converts propionyl-CoA into D-methylmalonyl-CoA, which is then racemized into L-methylmalonyl-CoA and isomerized into succinyl-CoA, <a href="/books/NBK1231/figure/mma.F1/?report=objectonly" target="object" rid-ob="figobmmaF1">(more...)</a></p></div></div><p>Isolated methylmalonic acidemia results from any ONE of the following:</p><ul><li class="half_rhythm"><div>Complete (<i>mut<sup>0</sup></i> enzymatic subtype) deficiency or partial (<i>mut<sup>&#x02013;</sup></i> enzymatic subtype) deficiency of the enzyme methylmalonyl-CoA mutase encoded by <i>MMUT</i></div></li><li class="half_rhythm"><div>Diminished synthesis of its cofactor 5'-deoxyadenosylcobalamin, associated with <i>cblA</i>, <i>cblB</i>, or <i>cblD-</i>MMA complementation groups caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MMAA, MMAB,</i> or <i>MMADHC</i>, respectively</div></li><li class="half_rhythm"><div>Deficient activity of methylmalonyl-CoA epimerase encoded by <i>MCEE</i></div></li></ul><p>Note that the following disorders are NOT included in the scope of this <i>GeneReview</i> (see <a href="#mma.Differential_Diagnosis">Differential Diagnosis</a>):</p><ul><li class="half_rhythm"><div>Methylmalonic acidemia associated with succinyl-CoA ligase deficiency, caused by mutation of <i>SUCLA2</i> or <i>SUCLG1</i>, is discussed in <a href="/books/n/gene/sucla2-def/"><i>SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a> and <a href="/books/n/gene/suclg1-mtddepl/"><i>SUCLG1</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a>, respectively.</div></li><li class="half_rhythm"><div>Methylmalonic acidemia associated with hyperhomocysteinemia or homocystinuria caused by defects in other steps of intracellular cobalamin metabolism is discussed in <a href="/books/n/gene/cbl/">Disorders of Intracellular Cobalamin Metabolism</a>.</div></li><li class="half_rhythm"><div>Rare defects, such as combined malonic and methylmalonic acidemia, methylmalonate semialdehyde dehydrogenase deficiency, transcobalamin receptor deficiency, and combined methylmalonic acidemia and homocysteinemia, <i>cblX</i> type, are discussed briefly under <a href="#mma.Differential_Diagnosis">Differential Diagnosis</a>.</div></li></ul><div id="mma.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Because the presenting signs and symptoms of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia are nonspecific, suggestive findings can include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">In neonates: lethargy, vomiting, hypotonia, hypothermia, respiratory distress, severe ketoacidosis, hyperammonemia, neutropenia, and thrombocytopenia</div><div class="half_rhythm">Note: In states with an expanded <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> program, <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia can be diagnosed in well-appearing newborns prior to an episode of acute decompensation.</div></li><li class="half_rhythm"><div class="half_rhythm">In older infants and children: failure to thrive, renal syndromes and hypotonia, intellectual disability or other acute (basal ganglia stroke) and chronic neurologic symptoms</div></li></ul><p>In patients with partial <i>mut</i> enzymatic deficiency, <i>cblA</i>, or <i>cblB,</i> suggestive findings at various ages can include the following:</p><ul><li class="half_rhythm"><div>An attenuated MMA <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</a>, <a class="bk_pop" href="#mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</a>, <a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>]</div></li><li class="half_rhythm"><div>Isolated renal tubular acidosis or chronic renal failure [<a class="bk_pop" href="#mma.REF.dudley.1998.564">Dudley et al 1998</a>, <a class="bk_pop" href="#mma.REF.coman.2006.270">Coman et al 2006</a>]</div></li><li class="half_rhythm"><div>Metabolic stroke of the basal ganglia [<a class="bk_pop" href="#mma.REF.korf.1986.364">Korf et al 1986</a>, <a class="bk_pop" href="#mma.REF.heidenreich.1988.1022">Heidenreich et al 1988</a>]</div></li><li class="half_rhythm"><div>Catastrophic/lethal ketoacidosis following an intercurrent illness [<a class="bk_pop" href="#mma.REF.ciani.2000.2119">Ciani et al 2000</a>]</div></li></ul></div><div id="mma.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>An overview of the process of <a href="/books/n/gene/cbl/">intracellular propionate and cobalamin metabolism</a> is depicted in <a class="figpopup" href="/books/NBK1231/figure/mma.F1/?report=objectonly" target="object" rid-figpopup="figmmaF1" rid-ob="figobmmaF1">Figure 1</a>. A flowchart for the work up of a person with elevated methylmalonic acid in urine and/or plasma is provided in <a class="figpopup" href="/books/NBK1231/figure/mma.F2/?report=objectonly" target="object" rid-figpopup="figmmaF2" rid-ob="figobmmaF2">Figure 2</a>, a modified algorithm that includes the consideration of methylmalonyl-CoA epimerase deficiency, succinyl-CoA ligase deficiency, and other rare defects in the pathway, as well as the use of in vivo vitamin B<sub>12</sub> responsiveness in the work up of an individual who is found to have methylmalonic acidemia at any age.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmmaF2" co-legend-rid="figlgndmmaF2"><a href="/books/NBK1231/figure/mma.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figmmaF2" rid-ob="figobmmaF2"><img class="small-thumb" src="/books/NBK1231/bin/mma-Image002.gif" src-large="/books/NBK1231/bin/mma-Image002.jpg" alt="Figure 2. . An algorithm of conditions to be considered in the differential diagnosis of elevated serum or urine methylmalonic acid detected either during the follow up of an increased propionylcarnitine (C3) on newborn screening or a positive urine organic acid screen in a symptomatic individual." /></a><div class="icnblk_cntnt" id="figlgndmmaF2"><h4 id="mma.F2"><a href="/books/NBK1231/figure/mma.F2/?report=objectonly" target="object" rid-ob="figobmmaF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">An algorithm of conditions to be considered in the differential diagnosis of elevated serum or urine methylmalonic acid detected either during the follow up of an increased propionylcarnitine (C3) on newborn screening or a positive urine organic acid <a href="/books/NBK1231/figure/mma.F2/?report=objectonly" target="object" rid-ob="figobmmaF2">(more...)</a></p></div></div><p><b>Step 1.</b> In a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suspicious clinical findings and a positive urine organic acid screen for MMA, laboratory testing that can help to establish the diagnosis includes: glucose, electrolytes, ammonia, blood gas, lactate, CBC, and urine ketones, plasma MMA, tHcy, and B<sub>12</sub> levels, plasma amino acids, and acylcarnitine profile. Relevant findings:</p><ul><li class="half_rhythm"><div>High plasma and urine MMA with normal B<sub>12</sub>, tHcy, and methionine levels</div></li><li class="half_rhythm"><div>Elevated propionylcarnitine (C3)</div></li><li class="half_rhythm"><div>High anion gap metabolic acidosis in arterial or venous blood gas testing and huge quantities of ketone bodies and lactate in the urine</div></li><li class="half_rhythm"><div>Hyperammonemia</div></li><li class="half_rhythm"><div>Hyperglycinemia</div></li><li class="half_rhythm"><div>Lactic acidosis</div></li><li class="half_rhythm"><div>CBC showing neutropenia, thrombocytopenia, anemia</div></li></ul><p><b>Step 2.</b> In newborns found to have elevation of propionylcarnitine (C3) by expanded <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> and in individuals at high genetic risk for the disorder (e.g., sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>), the first priority is to establish the presence of significantly elevated methylmalonic acid, which is best done by urine organic acid analysis (by GC/MS) and plasma acylcarnitine profile (by TMS). Note: At the same time, obtaining levels of plasma MMA, amino acids, plasma homocysteine, and serum vitamin B<sub>12</sub> (in both the newborn and the mother) helps further differentiate the cause of methylmalonic acidemia should that be confirmed (see <b>Step 3</b>).</p><p>In addition to elevated methylmalonic acid, the following biochemical findings may also be seen:</p><ul><li class="half_rhythm"><div>Presence of 3-hydroxypropionate, 2-methylcitrate, and tiglylglycine detected on GC/MS analysis of urine</div></li><li class="half_rhythm"><div>Elevated plasma concentration of glycine on plasma amino acid analysis</div></li><li class="half_rhythm"><div>Elevated plasma concentration of propionylcarnitine (C3) and variable elevations in C4-dicarboxylic or methylmalonic/succinylcarnitine (C4DC) measured by TMS</div></li></ul><p><b>Step 3.</b> Once elevation of methylmalonic acidemia and aciduria have been established, a normal plasma homocysteine and vitamin B<sub>12</sub> level can help differentiate <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> MMA from other disorders (see <a class="figpopup" href="/books/NBK1231/figure/mma.F2/?report=objectonly" target="object" rid-figpopup="figmmaF2" rid-ob="figobmmaF2">Figure 2</a>, left two columns). Note: Although plasma and/or urine methylmalonic acid concentration can be precisely quantitated (<a class="figpopup" href="/books/NBK1231/table/mma.T.methylmalonic_acid_concentration_i/?report=objectonly" target="object" rid-figpopup="figmmaTmethylmalonicacidconcentrationi" rid-ob="figobmmaTmethylmalonicacidconcentrationi">Table 1</a>), this is generally not needed immediately for diagnostic purposes.</p><div id="mma.T.methylmalonic_acid_concentration_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Methylmalonic Acid Concentration in Phenotypes and Enzymatic Subtypes of Methylmalonic Acidemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.T.methylmalonic_acid_concentration_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.T.methylmalonic_acid_concentration_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" style="text-align:left;vertical-align:middle;">Methylmalonic Acidemia Phenotype/Enzymatic Subtype&#x000a0;<sup>1</sup></th><th id="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Methylmalonic Acid Concentration</th></tr><tr><th headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2" id="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Urine&#x000a0;<sup>2</sup></th><th headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2" id="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Blood</th></tr></thead><tbody><tr><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infantile/non-B<sub>12</sub>-responsive&#x000a0;<sup>3</sup><br /><i>mut</i><sup>0</sup>, <i>mut<sup>&#x02013;</sup></i>, <i>cblB</i></td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1,000-10,000 mmol/mol Cr</td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100-1,000 &#x000b5;mol/L</td></tr><tr><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">B<sub>12</sub>-responsive&#x000a0;<sup>3</sup>
<i>cblA</i>, <i>cblD</i>-MMA<br /><i>cblB</i>, <i>mut</i><sup>&#x02013;</sup> (rare)</td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tens - hundreds mmol/mol Cr</td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5-100 &#x000b5;mol/L</td></tr><tr><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">"Benign"/adult methylmalonic acidemia&#x000a0;<sup>4</sup></td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10-100 mmol/mol Cr</td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100 &#x000b5;mol/L</td></tr><tr><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MCEE deficiency&#x000a0;<sup>5</sup></td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50-1,500 mmol/mol Cr</td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7 &#x000b5;mol/L</td></tr><tr><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal&#x000a0;<sup>6</sup></td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;4 mmol/mol Cr&#x000a0;<sup>7</sup></td><td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;0.27 &#x000b5;mol/L&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MCEE = methylmalonyl-CoA epimerase; ND = not determined</p></div></dd><dt>1. </dt><dd><div id="mma.TF.1.1"><p class="no_margin">Biochemical parameters and clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are not always concordant, partly because renal function can influence plasma MMA concentration [<a class="bk_pop" href="#mma.REF.kruszka.2013.990">Kruszka et al 2013</a>, <a class="bk_pop" href="#mma.REF.manoli.2013.13552">Manoli et al 2013</a>]. Patients in kidney failure show massive elevations in plasma MMA that can exceed 5,000 &#x000b5;mol/L.</p></div></dd><dt>2. </dt><dd><div id="mma.TF.1.2"><p class="no_margin">In some centers, analysis of urine by <sup>1</sup>H-NMR spectroscopy can also be used to demonstrate increased methylmalonate concentration [<a class="bk_pop" href="#mma.REF.iles.1986.173">Iles et al 1986</a>].</p></div></dd><dt>3. </dt><dd><div id="mma.TF.1.3"><p class="no_margin">Approximate numbers, representing the author's experience with &#x0003e;80 individuals with the B<sub>12</sub>-responsive and non-B<sub>12</sub>-responsive types</p></div></dd><dt>4. </dt><dd><div id="mma.TF.1.4"><p class="no_margin">From <a class="bk_pop" href="#mma.REF.giorgio.1976.310">Giorgio et al [1976]</a> and converted into &#x000b5;mol/L for plasma concentration</p></div></dd><dt>5. </dt><dd><div id="mma.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#mma.REF.bikker.2006.640">Bikker et al [2006]</a>, <a class="bk_pop" href="#mma.REF.dobson.2006.327">Dobson et al [2006]</a>, <a class="bk_pop" href="#mma.REF.nagarajan.2005.517">Nagarajan et al [2005]</a>, <a class="bk_pop" href="#mma.REF.gradinger.2007.1045">Gradinger et al [2007]</a></p></div></dd><dt>6. </dt><dd><div id="mma.TF.1.6"><p class="no_margin">From <a class="bk_pop" href="#mma.REF.gradinger.2007.1045">Gradinger et al [2007]</a></p></div></dd><dt>7. </dt><dd><div id="mma.TF.1.7"><p class="no_margin">Normal values have not been exclusively derived from children or neonates. Some laboratories report urine MMA concentrations in mg/g/Cr (normal: &#x0003c;3 mg/g/Cr) and serum concentrations in nmol/L (normal: &#x0003c;271 nmol/L). The molecular weight of MMA is 118 g/mol.</p></div></dd></dl></div></div></div><p><b>Step 4.</b> In vivo responsiveness to vitamin B<sub>12</sub> should be determined in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. No standard regimen has been documented. When stable, affected individuals can be given 1.0 mg of hydroxocobalamin (OH-Cbl) (see Note) intramuscularly or intravenously every day for one to two weeks followed by assessment of production of MMA and related metabolites (3-OH-propionic, 2-methylcitrate) by serial urine organic acid analyses and/or measurement of plasma concentrations of MMA, propionylcarnitine, and homocysteine. A significant (&#x0003e;50%) reduction in metabolite production and plasma concentration(s) is considered to indicate responsiveness [<a class="bk_pop" href="#mma.REF.fowler.2008.350">Fowler et al 2008</a>, <a class="bk_pop" href="#mma.REF.kruszka.2013.990">Kruszka et al 2013</a>]. In vivo response was reported in all individuals with <i>cblA</i> and only rare individuals with <i>cblB</i> [<a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>].</p><p>Note: Hydroxocobalamin (not cyanocobalamin) is the preferred preparation for treatment of methylmalonic acidemia; thus, if the in vivo response to intramuscular hydroxocobalamin is questionable or borderline, vitamin B<sub>12</sub> administration should be continued and a skin biopsy should be obtained to isolate fibroblasts to assess B<sub>12</sub> responsiveness by <sup>14</sup>C propionate incorporation in vitro.</p><p><b>Step 5.</b> Molecular genetic testing (<a class="figpopup" href="/books/NBK1231/table/mma.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figmmaTmoleculargenetictestingusedin" rid-ob="figobmmaTmoleculargenetictestingusedin">Table 2</a>) can be used to establish the diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> MMA by identifying <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the five genes (<i>MMUT, MMAA</i>, <i>MMAB</i>, <i>MCEE</i>, and <i>MMADHC</i>) and confirming <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status in the parents. In addition, the enzymatic subtype of isolated methylmalonic acidemia is mostly determined by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> due to the limited access to, cost of, and invasive nature of cellular biochemical testing.</p><p>Molecular testing approaches can include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Tiered single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia can be identical regardless of the mutated gene, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be performed in the following order:</div><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin"><i>UT</i> and <i>MMAB</i> in vitamin B<sub>12</sub>-non-responsive individuals</p></dd><dt>2.</dt><dd><p class="no_top_margin"><i>MMAA</i> in vitamin B<sub>12</sub>-responsive individuals</p></dd><dt>3.</dt><dd><p class="no_top_margin"><i>MCEE</i> and <i>MMADHC</i> testing if results of testing of the first three genes (<i>MMUT,</i>
<i>MMAB,</i> and <i>MMAA)</i> are unrevealing</p></dd></dl><div class="half_rhythm">Note: For all genes, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> is performed first, followed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been detected.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes these five genes and other genes in the metabolic pathway (see <a href="#mma.Differential_Diagnosis">Differential Diagnosis</a>). Note: The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="mma.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Isolated Methylmalonic Acidemia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of Isolated MMA Attributed to Mutation of This Gene&#x000a0;<sup>2</sup></th><th id="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Variants Detected by This Method</th></tr><tr><th headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></th><th headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMUT</i></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60%<br />(78% <i>mut</i><sup>0</sup> enzymatic subtype, 22% <i>mut</i><sup>&#x02013;</sup> enzymatic subtype)</td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">96%&#x000a0;<sup>5,&#x000a0;6</sup></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported</td></tr><tr><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMAA</i></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">25%</td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">97%&#x000a0;<sup>7</sup></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported</td></tr><tr><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMAB</i></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%</td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">98%&#x000a0;<sup>8</sup></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported</td></tr><tr><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MCEE</i></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 probands/families&#x000a0;<sup>9</sup></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported</td></tr><tr><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMADHC</i></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6 probands/families&#x000a0;<sup>10</sup></td><td headers="hd_h_mma.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_mma.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mma.TF.2.1"><p class="no_margin">See <a href="/books/NBK1231/#mma.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#mma.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="mma.TF.2.2"><p class="no_margin">Based on <a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al [2006]</a> and <a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al [2007]</a></p></div></dd><dt>3. </dt><dd><div id="mma.TF.2.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="mma.TF.2.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="mma.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al [2006]</a></p></div></dd><dt>6. </dt><dd><div id="mma.TF.2.6"><p class="no_margin">For individuals of Hispanic descent, targeted <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 analysis for the <i>MMUT</i>
<a class="figpopup" href="/books/NBK1231/table/mma.T.mmut_pathogenic_missense_variants/?report=objectonly" target="object" rid-figpopup="figmmaTmmutpathogenicmissensevariants" rid-ob="figobmmaTmmutpathogenicmissensevariants">c.322C&#x0003e;T</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may be considered.</p></div></dd><dt>7. </dt><dd><div id="mma.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#mma.REF.lernerellis.2004.509">Lerner-Ellis et al [2004]</a></p></div></dd><dt>8. </dt><dd><div id="mma.TF.2.8"><p class="no_margin"><a class="bk_pop" href="#mma.REF.lernerellis.2006.219">Lerner-Ellis et al [2006]</a></p></div></dd><dt>9. </dt><dd><div id="mma.TF.2.9"><p class="no_margin"><a class="bk_pop" href="#mma.REF.gradinger.2007.1045">Gradinger et al [2007]</a></p></div></dd><dt>10. </dt><dd><div id="mma.TF.2.10"><p class="no_margin"><a class="bk_pop" href="#mma.REF.stucki.2012.1410">Stucki et al [2012]</a></p></div></dd></dl></div></div></div><p><b>Step 6.</b> Cellular biochemical testing on skin fibroblasts is the gold standard for determining the MMA subtype and B<sub>12</sub> responsiveness in vitro and is useful when the above testing methods fail to provide a firm diagnosis to guide management. For details of biochemical testing, click <a href="/books/NBK1231/bin/mma-biochem_testing.pdf">here</a> (pdf).</p><div id="mma.Newborn_Screening"><h4>Newborn Screening</h4><p>In the past decade, the implementation of tandem mass spectrometry (MS/MS) in <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (NBS) by many states in the US and countries worldwide has identified newborns with methylmalonic acidemia through detection of elevated concentration of blood propionylcarnitine (C3), a metabolite increased in the blood of individuals with methylmalonic acidemia and the related disorder, propionic acidemia [<a class="bk_pop" href="#mma.REF.chace.2001.2040">Chace et al 2001</a>, <a class="bk_pop" href="#mma.REF.therrell.2014.14">Therrell et al 2014</a>].</p><p>Note: Since propionylcarnitine is one of the analytes most frequently responsible for false positive results, ratios including C3/C2, C3/C0, C3/C16, and new biomarkers such as C16:1OH are recommended in combination with high blood concentration of C3 as decision criteria for "positive" testing in <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> acylcarnitine analysis by MS/MS for methylmalonic acidemia and propionic acidemia [<a class="bk_pop" href="#mma.REF.lindner.2008.379">Lindner et al 2008</a>].</p><p>Second-tier testing of 3-hydroxypropionic, methylmalonic, and/or 2-methylcitric acids could be used to reduce the costs and anxiety associated with false positive results [<a class="bk_pop" href="#mma.REF.matern.2007.585">Matern et al 2007</a>, <a class="bk_pop" href="#mma.REF.la_marca.2008.s395">la Marca et al 2008</a>].</p><ul><li class="half_rhythm"><div>If C3 and C5OH are increased, the diagnosis of holocarboxylase deficiency and/or <a href="/books/n/gene/biotin/">biotinidase deficiency</a> needs to be considered.</div></li><li class="half_rhythm"><div>Elevated C4-dicarboxylic acylcarnitine (C4DC) is a marker for both methylmalonylcarnitine and succinylcarnitine, and can indicate methylmalonic aciduria associated with succinyl-CoA ligase deficiency [<a class="bk_pop" href="#mma.REF.fowler.2008.350">Fowler et al 2008</a>, <a class="bk_pop" href="#mma.REF.morava.2009.438">Morava et al 2009</a>].</div></li></ul><p>Recommended action (ACT) sheet and confirmatory algorithm describing the basic necessary steps involved in follow up of an infant who has screened positive are available; see American College of Medical Genetics (ACMG) <a href="http://www.acmg.net/PDFLibrary/C3-DC.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Newborn Screening ACT Sheet</a> and <a href="http://www.clinchem.org/content/55/9/1615.long" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">National Academy of Clinical Biochemistry Guidelines</a> (pdf) [<a class="bk_pop" href="#mma.REF.dietzen.2009.1615">Dietzen et al 2009</a>].</p></div></div></div><div id="mma.Clinical_Characteristics"><h2 id="_mma_Clinical_Characteristics_">Clinical Characteristics</h2><div id="mma.Clinical_Description"><h3>Clinical Description</h3><p>The phenotypes of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia described below that are associated with the <i>mut<sup>0</sup></i> enzymatic subtype, <i>mut<sup>&#x02013;</sup></i> enzymatic subtype, <i>cblA</i>, <i>cblB</i>, and <i>cblD</i>-MMA share clinical presentations and a natural history characterized by periods of relative health and intermittent metabolic decompensation, usually associated with intercurrent infections and stress [<a class="bk_pop" href="#mma.REF.zwickler.2012.797">Zwickler et al 2012</a>]. Each such decompensation can be life-threatening. Of note, the natural history of isolated methylmalonic acidemia requires further study, particularly with respect to medical complications including renal disease, the effect of solid organ transplantation, and molecular pathology.</p><p><b>Infantile/non-B<sub>12</sub>-responsive <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (<i>mut<sup>0</sup></i> enzymatic subtype, <i>cblB</i>).</b> The most common phenotype of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia presents during infancy. Infants are normal at birth but rapidly develop lethargy, vomiting, and dehydration on initiation of protein-containing feeds. At presentation, they exhibit hepatomegaly, hypotonia, and in many, hyperammonemic encephalopathy. Laboratory findings typically show a severe, high anion-gap metabolic acidosis, ketosis and ketonuria (highly abnormal in neonates and strongly suggestive of an organic aciduria), hyperammonemia, and hyperglycinemia [<a class="bk_pop" href="#mma.REF.matsui.1983.857">Matsui et al 1983</a>, <a class="bk_pop" href="#mma.REF.k_lker.2015a.1041">K&#x000f6;lker et al 2015a</a>]. Dialysis may be needed especially if hyperammonemia is significant and persistent.</p><p>Thrombocytopenia and neutropenia, suggestive of neonatal sepsis, can be seen.</p><p>The catastrophic neonatal presentation of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia can result in death, despite aggressive intervention. Infants with the B<sub>12</sub>-responsive <i>mut<sup>&#x02013;</sup></i> enzymatic subtype or <i>cblA</i> can also present with an acute neonatal crisis.</p><p><b>Partially deficient or B<sub>12</sub>-responsive phenotypes (<i>mut</i></b><i><sup>&#x02013;</sup></i>
<b>enzymatic subtype, <i>cblA</i>, <i>cblB</i> [rare], <i>cblD</i>-MMA).</b> This intermediate <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia can occur in the first few months or years of life. Affected infants can exhibit feeding problems (typically anorexia and vomiting), failure to thrive, hypotonia, and developmental delay. Some have protein aversion and/or clinical symptoms of vomiting and lethargy after protein intake.</p><p>Until the diagnosis is established and treatment initiated these infants are at risk for a catastrophic decompensation (like that in neonates) [<a class="bk_pop" href="#mma.REF.shapira.1991.80">Shapira et al 1991</a>, <a class="bk_pop" href="#mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</a>, <a class="bk_pop" href="#mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</a>, <a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>].</p><p>During such an episode of metabolic decompensation, the child may die despite intensive intervention if prompt treatment specific for MMA is not instituted and the symptoms are misdiagnosed as, for example, diabetic ketoacidosis [<a class="bk_pop" href="#mma.REF.ciani.2000.2119">Ciani et al 2000</a>].</p><p>Before the onset of <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a>, infants with the subtypes <i>cblA</i> or <i>mut<sup>&#x02013;</sup></i> would present with a devastating injury in the basal ganglia (more specifically lacunar infarcts in the globus pallidus) resulting in a debilitating movement disorder [<a class="bk_pop" href="#mma.REF.korf.1986.364">Korf et al 1986</a>, <a class="bk_pop" href="#mma.REF.heidenreich.1988.1022">Heidenreich et al 1988</a>].</p><p>Patients with partial <i>mut</i> enzymatic deficiency, <i>cblA</i>, or <i>cblB</i> can also present with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> renal tubular acidosis or chronic renal failure [<a class="bk_pop" href="#mma.REF.dudley.1998.564">Dudley et al 1998</a>, <a class="bk_pop" href="#mma.REF.coman.2006.270">Coman et al 2006</a>].</p><p><b>Methylmalonyl-CoA epimerase deficiency.</b> Pathogenic variants in <i>MCEE</i> are a very rare cause of persistent moderate methylmalonic aciduria. Findings in infants/children with mutation of <i>MCEE</i> have ranged from complete absence of symptoms to severe metabolic acidosis with increased MMA and 2-methylcitrate and ketones in the urine at initial presentation [<a class="bk_pop" href="#mma.REF.dobson.2006.327">Dobson et al 2006</a>, <a class="bk_pop" href="#mma.REF.gradinger.2007.1045">Gradinger et al 2007</a>]. Symptoms include ataxia, dysarthria, hypotonia, mild spastic paraparesis, and seizures; however, many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons were from <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> unions &#x02014; including the first identified individual, who also had a DOPA-responsive dystonia resulting from <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants of <i>SPR</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding sepiapterin reductase [<a class="bk_pop" href="#mma.REF.bikker.2006.640">Bikker et al 2006</a>].</p><p><b>Secondary complications.</b> Despite increased knowledge about <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia and possibly earlier symptomatic diagnosis, isolated methylmalonic acidemia continues to be associated with substantial morbidity and mortality [<a class="bk_pop" href="#mma.REF.de_baulny.2005.415">de Baulny et al 2005</a>, <a class="bk_pop" href="#mma.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</a>, <a class="bk_pop" href="#mma.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</a>] that correlates with the underlying defect [<a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>]. Individuals with the <i>mut<sup>0</sup></i> enzymatic subtype and the <i>cblB</i> subtype have a higher rate of mortality and neurologic complications than those with the <i>mut<sup>&#x02013;</sup></i> enzymatic subtype and <i>cblA</i>.</p><p>The major secondary complications include:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Intellectual disability.</b> Intellectual disability may or may not be present even in those with severe disease. In a retrospective, survey-based review, about 50% of individuals with the <i>mut<sup>0</sup></i> enzymatic subtype and 25% of those with the <i>cblA</i>/<i>cblB</i> enzymatic subtype had an IQ below 80 and significant neurologic impairment [<a class="bk_pop" href="#mma.REF.baumgarter.1995.138">Baumgarter &#x00026; Viardot 1995</a>].</div><div class="half_rhythm">In another study about 50% of individuals with <i>mut<sup>0</sup></i>, 85% with <i>mut</i><sup>&#x02013;</sup>, 48% with <i>cblA</i>, and 70% with <i>cblB</i> had an IQ above 90 [<a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>].</div><div class="half_rhythm">In a recent natural history study, the mean FSIQ of all individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia (n = 37) was 85.0 &#x000b1; 20.68, which is in the low average range (80 &#x02264; IQ &#x02264;89). Individuals with <i>cblA</i> (n = 7), <i>cblB</i> (n = 6), and <i>mut</i> diagnosed prenatally or by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (n = 3) had mean FSIQs in the average range (90 &#x02264; IQ &#x02264;109). The age of disease onset, the presence of severe hyperammonemia at diagnosis, and a history of seizures were associated with more severe impairments [<a class="bk_pop" href="#mma.REF.oshea.2012.e1541">O'Shea et al 2012</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Tubulointerstitial nephritis with progressive impairment of renal function.</b> All individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia, even those who are mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or who have received a liver allograft [<a class="bk_pop" href="#mma.REF.nyhan.2002.377">Nyhan et al 2002</a>], are at risk of developing renal insufficiency [<a class="bk_pop" href="#mma.REF.walter.1989.344">Walter et al 1989</a>, <a class="bk_pop" href="#mma.REF.kruszka.2013.990">Kruszka et al 2013</a>]. End-stage renal disease (ESRD) was common in individuals with the <i>mut<sup>0</sup></i> enzymatic subtype (61%) and the <i>cblB</i> (66%) enzymatic subtype, and occurred less frequently in those with the <i>cblA</i> (21%) enzymatic subtype [<a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>].</div><div class="half_rhythm">Secondary mitochondrial dysfunction rather than direct nephrotoxicity of methylmalonic acid is hypothesized. Cell-specific mitochondrial pathology primarily in the proximal tubules, associated with cytochrome <i>c</i> oxidase deficiency and increased markers of oxidative stress in the urine and plasma, have been shown in human and mouse studies [<a class="bk_pop" href="#mma.REF.atkuri.2009.3941">Atkuri et al 2009</a>, <a class="bk_pop" href="#mma.REF.mc_guire.2009.173">Mc Guire et al 2009</a>, <a class="bk_pop" href="#mma.REF.manoli.2013.13552">Manoli et al 2013</a>, <a class="bk_pop" href="#mma.REF.zsengell_r.2014.2139">Zsengell&#x000e9;r et al 2014</a>].</div><div class="half_rhythm">An acute renal syndrome, seen in the setting of metabolic decompensation, may also exist [<a class="bk_pop" href="#mma.REF.stokke.1967.313">Stokke et al 1967</a>] and requires further clinical delineation. Moreover, renal tubular dysfunction presenting as a decrease in urine concentrating ability and acidification, hyporeninemic hypoaldosteronism, tubular acidosis type 4, and hyperkalemia have been reported in a number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, and are supported by murine studies [<a class="bk_pop" href="#mma.REF.walter.1989.344">Walter et al 1989</a>, <a class="bk_pop" href="#mma.REF.dangio.1991.259">D'Angio et al 1991</a>, <a class="bk_pop" href="#mma.REF.pela.2006.63">Pela et al 2006</a>, <a class="bk_pop" href="#mma.REF.manoli.2013.13552">Manoli et al 2013</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Neurologic findings.</b> Some individuals develop a "metabolic stroke" or infarction of the basal ganglia (characteristically the globus pallidus externa) during acute metabolic decompensation, which can produce an incapacitating movement disorder [<a class="bk_pop" href="#mma.REF.korf.1986.364">Korf et al 1986</a>, <a class="bk_pop" href="#mma.REF.heidenreich.1988.1022">Heidenreich et al 1988</a>]. The reported incidence in different cohorts is 17%-30% [<a class="bk_pop" href="#mma.REF.baumgarter.1995.138">Baumgarter &#x00026; Viardot 1995</a>, <a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>]. Distinct segments of the globus pallidus (and sometimes the substrantia nigra in the cerebral peduncles) are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, suggesting a non-uniform, cell-specific sensitivity to the mechanism of infarct [<a class="bk_pop" href="#mma.REF.baker.2015.194">Baker et al 2015</a>].</div><div class="half_rhythm">Delayed myelination, incomplete opercularization, subcortical white matter changes, and brain stem and cerebellar changes have been described [<a class="bk_pop" href="#mma.REF.harting.2008.368">Harting et al 2008</a>, <a class="bk_pop" href="#mma.REF.radmanesh.2008.1054">Radmanesh et al 2008</a>].</div><div class="half_rhythm">Of note, individuals who have undergone liver and/or kidney transplantation can develop acute lesions without overt metabolic decompensation, suggesting that the enzyme deficiency in the brain remains unchanged and trapping of toxic metabolites in the CNS compartment can lead to injury despite other systemic benefits of the transplantation [<a class="bk_pop" href="#mma.REF.chakrapani.2002.261">Chakrapani et al 2002</a>, <a class="bk_pop" href="#mma.REF.kaplan.2006.322">Kaplan et al 2006</a>, <a class="bk_pop" href="#mma.REF.vernon.2014.899">Vernon et al 2014</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Pancreatitis.</b> The incidence of pancreatitis in <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia is unknown, but it is a well-recognized complication [<a class="bk_pop" href="#mma.REF.kahler.1994.239">Kahler et al 1994</a>]. It can occur acutely or chronically. Pancreatitis may be under-recognized because it can manifest nonspecifically with vomiting and abdominal pain.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Growth failure.</b> Growth failure is frequent and <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a>. It is the result of severe chronic illness and perhaps relative protein malnutrition that is complicated further by chronic renal failure. Many infants are less than three standard deviations below normal for both length and weight.</div><div class="half_rhythm">Some children have documented growth hormone (GH) deficiency, but response to GH therapy may vary (see <a href="#mma.Management">Management</a>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Functional immune impairment.</b> This results in an increased susceptibility to severe infections, particularly by fungal and gram-negative organisms [<a class="bk_pop" href="#mma.REF.oberholzer.1967.492">Oberholzer et al 1967</a>, <a class="bk_pop" href="#mma.REF.wong.1992.180">Wong et al 1992</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Bone marrow failure.</b> During episodes of metabolic decompensation patients can exhibit pancytopenia, with bone marrow hypoplasia and/or dysplasia that most frequently revert to normal with supportive care.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Optic nerve atrophy.</b> Late-onset optic atrophy associated with acute visual loss, resembling the presentation of the mitochondrial disorder <a href="/books/n/gene/lhon/">Leber hereditary optic neuropathy</a> (LHON), has been reported in <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia [<a class="bk_pop" href="#mma.REF.wasserstein.1999.788">Wasserstein et al 1999</a>, <a class="bk_pop" href="#mma.REF.williams.2009.929">Williams et al 2009</a>, <a class="bk_pop" href="#mma.REF.pinarsueiro.2010.s199">Pinar-Sueiro et al 2010</a>, <a class="bk_pop" href="#mma.REF.traber.2011.344">Traber et al 2011</a>], as well as in propionic acidemia [<a class="bk_pop" href="#mma.REF.williams.2009.929">Williams et al 2009</a>, <a class="bk_pop" href="#mma.REF.martinez_alvarez.2016.98">Martinez Alvarez et al 2016</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Hepatoblastoma</b>. Isolated instances of hepatoblastoma have been reported in the native or donor liver in individuals with <i>mut</i> MMA; however, the overall incidence of cancer in these patients is unknown [<a class="bk_pop" href="#mma.REF.cosson.2008.107">Cosson et al 2008</a>, <a class="bk_pop" href="#mma.REF.chan.2015.635">Chan et al 2015</a>]</div></li></ul><p><b>Survival</b> in <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia has improved over time [<a class="bk_pop" href="#mma.REF.matsui.1983.857">Matsui et al 1983</a>, <a class="bk_pop" href="#mma.REF.van_der_meer.1994.903">van der Meer et al 1994</a>, <a class="bk_pop" href="#mma.REF.baumgarter.1995.138">Baumgarter &#x00026; Viardot 1995</a>, <a class="bk_pop" href="#mma.REF.nicolaides.1998.508">Nicolaides et al 1998</a>, <a class="bk_pop" href="#mma.REF.k_lker.2015a.1041">K&#x000f6;lker et al 2015a</a>].</p><p>In those with the <i>mut<sup>0</sup></i> enzymatic subtype, survival at age one year has improved from 65% in the 1970s to more than 90% in the 1990s; five-year survival has improved from 33% in the 1970s to more than 80% in the 1990s.</p><p>In one series, the median age of death of those with the <i>mut<sup>0</sup></i> enzymatic subtype was compared over time: 100% died at a median age of 1.6 years in the 1970s, 50% died at a median age of 7.6 years in the 1980s, and 20% died at a median age of 2.2 years in the 1990s. Overall mortality was about 50% for those with the <i>mut<sup>0</sup></i> enzymatic subtype (median age of death 2 years) as compared to 50% for the <i>cblB</i> enzymatic subtype (median age of death 2.9 years), 40% for the <i>mut<sup>&#x02013;</sup></i> enzymatic subtype (median age of death 4.5 years), and about 5% for the <i>cblA</i> enzymatic subtype (1 death at 14 days) [<a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>].</p><p>The effect of early organ transplantation on overall survival has not been systematically studied.</p><p><b>Effect of <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a>.</b> The limited number of infants detected by newborn screening (NBS) and the short duration of their follow up do not allow conclusions regarding the effect of NBS on the long-term outcome of methylmalonic acidemia [<a class="bk_pop" href="#mma.REF.leonard.2003.s21">Leonard et al 2003</a>, <a class="bk_pop" href="#mma.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</a>]. Moreover, it must be emphasized that a significant number of infants with the <i>mut<sup>0</sup></i> enzymatic subtype may present clinically before the NBS results become available. Limited observations in sibs with the <i>cblA</i> enzymatic subtype suggest that the IQs of the individuals treated from the newborn period were significantly better than those of their older <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs who were diagnosed after the onset of symptoms [<a class="bk_pop" href="#mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</a>].</p><p>Of note, before the availability of <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> individuals with <i>cblA</i> and some with <i>cblB</i> often manifested in early childhood with encephalopathy and globus pallidus injury, which in theory could have been avoided if they had been detected by NBS and treated before symptoms appeared.</p></div><div id="mma.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Precise <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are difficult to determine since most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are compound heterozygotes.</p><p>Homozygosity for the <a class="figpopup" href="/books/NBK1231/table/mma.T.mmut_pathogenic_missense_variants/?report=objectonly" target="object" rid-figpopup="figmmaTmmutpathogenicmissensevariants" rid-ob="figobmmaTmmutpathogenicmissensevariants">p.Asn219Tyr</a>
<i>MMUT</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is frequently associated with severe mutase deficiency (i.e., the <i>mut<sup>0</sup></i> enzymatic subtype) [<a class="bk_pop" href="#mma.REF.acquaviva.2001.577">Acquaviva et al 2001</a>]. <a class="figpopup" href="/books/NBK1231/table/mma.T.mmut_pathogenic_missense_variants/?report=objectonly" target="object" rid-figpopup="figmmaTmmutpathogenicmissensevariants" rid-ob="figobmmaTmmutpathogenicmissensevariants">p.Arg108Cys</a>, which is also associated with a <i>mut<sup>0</sup></i> enzymatic subtype, is more common in individuals of Hispanic descent [<a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al 2006</a>].</p><p>Homozygosity for the <a class="figpopup" href="/books/NBK1231/table/mma.T.mmut_pathogenic_missense_variants/?report=objectonly" target="object" rid-figpopup="figmmaTmmutpathogenicmissensevariants" rid-ob="figobmmaTmmutpathogenicmissensevariants">p.Gly717Val</a>
<i>MMUT</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, which is associated with the <i>mut<sup>&#x02013;</sup></i> enzymatic subtype [<a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al 2006</a>], is more common in individuals of African descent.</p><p>The clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> depends on a number of factors that cannot be accurately predicted by the <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>, including whole-body enzyme activity, in vivo responsiveness to cobalamin, environmental factors, and perhaps the efficiency and activation of alternative propionyl-CoA disposal pathways. It is possible that better understanding of clinical correlations in <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia could be achieved by estimating the amount of whole-body residual metabolic capacity based on stable isotope studies [<a class="bk_pop" href="#mma.REF.leonard.1997.s67">Leonard 1997</a>].</p></div><div id="mma.Prevalence"><h3>Prevalence</h3><p>Several studies have estimated the birth prevalence of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia [<a class="bk_pop" href="#mma.REF.sniderman.1999.675">Sniderman et al 1999</a>]. Urine screening for isolated methylmalonic acidemia in Quebec identified "symptomatic methylmalonic aciduria" in approximately 1:80,000 newborns screened [<a class="bk_pop" href="#mma.REF.sniderman.1999.675">Sniderman et al 1999</a>], which approximates the observation of <a class="bk_pop" href="#mma.REF.chace.2001.2040">Chace et al [2001]</a> of ten cases of isolated methylmalonic acidemia identified in a sample of 908,543 newborns screened by mass spectrometry in the US.</p><p>In Japan, the birth prevalence may be as high as 1:50,000 [<a class="bk_pop" href="#mma.REF.shigematsu.2002.39">Shigematsu et al 2002</a>].</p><p>It appears that the prevalence of <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia may therefore fall between 1:50,000 and 1:100,000; confirmation, however, would require larger studies.</p></div></div><div id="mma.Genetically_Related_Allelic_Disorder"><h2 id="_mma_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MMUT</i>, <i>MMAA</i>, <i>MMAB</i>, or <i>MCEE.</i></p><p>One individual with <i>mut<sup>0</sup></i> MMA and insulin-dependent diabetes mellitus caused by paternal isodisomy of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 6 has been reported [<a class="bk_pop" href="#mma.REF.abramowicz.1994.418">Abramowicz et al 1994</a>].</p><p><i>MMADHC</i> <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants are also associated with <i>cblD</i>-combined (methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria) and <i>cblD</i>-homocystinuria (hyperhomocysteinemia/homocystinuria), which are discussed in <a href="/books/n/gene/cbl/">Disorders of Intracellular Cobalamin Metabolism</a>.</p></div><div id="mma.Differential_Diagnosis"><h2 id="_mma_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Atypical methylmalonic acidemia</b> is associated with increased, usually mild urinary excretion of methylmalonate. Rare defects, such as succinate-CoA ligase deficiency, combined malonic and methylmalonic aciduria, <i>cblX</i> deficiency, transcobalamin receptor defect, and methylmalonate semialdehyde dehydrogenase deficiency can cause methylmalonic acidemia/aciduria, although most patients will have additional biochemical findings.</p><p>The only known <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder related to the intracellular cobalamin metabolic pathway is <i>cblX</i> deficiency, caused by mutation of <i>HCFC1</i> and associated with combined methylmalonic acidemia and hyperhomocysteinemia, severe intellectual disability, complex seizures, and other neurologic findings. <i>cblX</i> deficiency is a recently described disorder with unknown spectrum, but likely to include X-linked developmental delay either without biochemical abnormalities or with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> elevations of methylmalonic acid.</p><p><b>"Benign" methylmalonic acidemia.</b> Newborn screening in the province of Quebec identified infants with mild-to-moderate urinary methylmalonic acid excretion. Follow up revealed resolution in more than 50% of children, as well as an apparently benign, persistent, low-moderate methylmalonic acidemia in some [<a class="bk_pop" href="#mma.REF.ledley.1984.1015">Ledley et al 1984</a>, <a class="bk_pop" href="#mma.REF.sniderman.1999.675">Sniderman et al 1999</a>]. Additional individuals with a relatively benign type of methylmalonic acidemia have been reported [<a class="bk_pop" href="#mma.REF.coulombe.1981.26">Coulombe et al 1981</a>, <a class="bk_pop" href="#mma.REF.martens.2002.219">Martens et al 2002</a>]. Caution is necessary in follow up of these individuals as some can belong to a mild <i>mut<sup>&#x02013;</sup></i> enzymatic subtype and carry a significant risk for acute metabolic crisis [<a class="bk_pop" href="#mma.REF.shapira.1991.80">Shapira et al 1991</a>].</p><p>The long-term outcome and clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of these individuals awaits further description. Of note, a subgroup had a combined biochemical phenotype of malonic and methylmalonic acidemia and therefore likely represents combined malonic and methylmalonic (CMAMMA) caused by ACSF3 deficiency.</p><p><b>Combined malonic and methylmalonic aciduria (CMAMMA) caused by ACSF3 deficiency.</b> Patients with CMAMMA show high malonic acid (MA) and methylmalonic acid (MMA) levels in their urine or plasma, with MMA excretion typically being higher than MA excretion (MMA/MA &#x0003e;5). Because C3 (propionylcarnitine) is not elevated, infants with CMAMMA are not detected by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> based on a dried blood spot acylcarnitine analysis.</p><p>The phenotypic spectrum is broad, ranging from completely asymptomatic individuals to adults with neurologic syndromes (seizures, memory problems, psychiatric disease, and/or cognitive decline) or children with a wide range of manifestations, such as coma, ketoacidosis, hypoglycemia, failure to thrive, elevated transaminases, microcephaly, dystonia, axial hypotonia, and/or developmental delay. The full natural history of this disorder remains to be elucidated.</p><p>Mutation of <i>ACSF3</i> (encoding a methylmalonyl- and malonyl-CoA synthetase that produces the first substrate, malonyl-CoA, for intra-mitochondrial fatty acid synthesis) is causative [<a class="bk_pop" href="#mma.REF.alfares.2011.602">Alfares et al 2011</a>, <a class="bk_pop" href="#mma.REF.sloan.2011.883">Sloan et al 2011</a>].</p><p><b>Methylmalonate semialdehyde dehydrogenase deficiency (MMSDH).</b> In the last enzymatic steps in the valine degradation pathway, 3-hydroxyisobutyrate dehydrogenase converts 3-hydroxyisobutyrate to (S)-methylmalonic semialdehyde (MMSA), and methylmalonate semialdehyde dehydrogenase (MMSDH) converts (S)-methylmalonic semialdehyde to propionyl-CoA). Of note, the same enzyme catalyzes the oxidative decarboxylation of the (R)-methylmalonic semialdehyde enantiomer generated from thymine metabolism to propionyl-CoA.</p><p>A small number of patients with pathogenic variants in <i>ALDH6A1</i>, which encodes the MMSDH enzyme, have had extremely variable biochemical phenotypes: some have displayed 3-hydroxyisobutyric aciduria [<a class="bk_pop" href="#mma.REF.chambliss.2000.497">Chambliss et al 2000</a>, <a class="bk_pop" href="#mma.REF.sass.2012.437">Sass et al 2012</a>], while others have also displayed transient methylmalonic acidemia/aciduria [<a class="bk_pop" href="#mma.REF.marcadier.2013.98">Marcadier et al 2013</a>]. They have also had extremely variable clinical phenotypes, including severe intellectual impairment associated with significant brain myelination defects.</p><p><b>Transcobalamin receptor defect (TCblR/CD320).</b> The index case and four additional <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals were asymptomatic newborns identified on NBS with an elevated C3 and elevated C3/C2 ratio. They also had increased plasma and urine MMA and normal serum vitamin B<sub>12</sub> levels; two of the four were stated to have elevated homocysteine.</p><p>In the index case, biochemical abnormalities normalized with a single hydroxocobalamin injection and remained normal for nine months [<a class="bk_pop" href="#mma.REF.quadros.2010.3033">Quadros et al 2010</a>]. Fibroblasts showed decreased uptake of transcobalamin.</p><p>A <i>CD320</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was also identified in a boy age seven weeks with retinal artery occlusions born to <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents [<a class="bk_pop" href="#mma.REF.karth.2012.398">Karth et al 2012</a>]. All reported <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for NM_016579.3:c.262_264del (p.Glu88del). Polymorphisms in the TCblR have been associated with increased risk for neural tube defects in an Irish cohort [<a class="bk_pop" href="#mma.REF.pangilinan.2010.677">Pangilinan et al 2010</a>].</p><p><b>Combined methylmalonic acidemia and</b>
<a href="/books/n/gene/cbl/"><b>hyperhomocysteinemia/homocystinuria</b></a><b>.</b> Disorders that interfere with the intracellular metabolism of cobalamin can cause a perturbation in the synthesis of adenosylcobalamin and/or methylcobalamin. However, these conditions are usually accompanied by clinically significant hyperhomocysteinemia. The following are included in this group of disorders:</p><ul><li class="half_rhythm"><div>Cobalamin C deficiency (<i>cblC</i>) is perhaps the most common inborn error of <a href="/books/n/gene/cbl/">intracellular cobalamin metabolism</a>. Individuals with this disorder almost always have increased plasma concentrations of homocysteine and methylmalonic acid, with low levels of methionine, and historically a highly variable age of onset. Affected individuals frequently have developmental delay and develop a pigmentary retinopathy and a "bull's eye" maculopathy. <i>cblC</i> is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>MMACHC</i> which encodes a protein involved in the processing and trafficking of intracellular cobalamin. The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.271dupA;p.Arg91LysfsTer14 accounts for approximately 40% of alleles [<a class="bk_pop" href="#mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</a>].</div></li><li class="half_rhythm"><div>Deficiencies of complementation groups <i>cblD</i>, <i>cblF</i>, and <i>cblJ</i> are extremely rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders.</div><ul><li class="half_rhythm"><div class="half_rhythm"><b><i>cblD</i> deficiency</b> is biochemically heterogeneous [<a class="bk_pop" href="#mma.REF.suormala.2004.42742">Suormala et al 2004</a>]. <a class="bk_pop" href="#mma.REF.coelho.2008.1454">Coelho et al [2008]</a> determined that mutation of <i>MMADHC</i> (previously known as <i>C2ORF25)</i> is responsible for <i>cblD</i> and identified <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations. <i>MMADHC</i> has multiple translation initiation codons (ATG), and encodes distant polypeptides. The location and nature of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> therefore determines whether a patient will display methylmalonic aciduria, homocystinuria, or both metabolic abnormalities:</div><ul><li class="half_rhythm"><div>The <i>cblD-</i>methylmalonic aciduria subtype (<i>cblD</i>-MMA) (previously known as <i>cblD-</i>variant 2) is caused by pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frame-shifting variants in exons 3 and 4;</div></li><li class="half_rhythm"><div>The <i>cblD-</i>homocystinuria subtype (previously known as <i>cblD</i> variant 1) is caused by pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in exons 6-8;</div></li><li class="half_rhythm"><div>A <i>cblD-</i>combined subtype (<i>cblD</i>) that features elevations of both MMA and homocysteine is caused by frame-shifting pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5, exon 8, and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 7.</div></li></ul><div class="half_rhythm">Note: Individuals with complementation <i>cblD</i>-homocystinuria [<a class="bk_pop" href="#mma.REF.coelho.2008.1454">Coelho et al 2008</a>], <i>cblE</i> (methionine synthase reductase), and <i>cblG</i> (methionine synthase) abnormalities do not have methylmalonic acidemia, but rather <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> homocystinuria/hyperhomocysteinemia caused by impaired methyl-cobalamin synthesis.</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>cblF</i> deficiency</b> is caused by mutation of <i>LMBRD1</i>, which encodes a putative lysosomal cobalamin exporter [<a class="bk_pop" href="#mma.REF.rutsch.2009.234">Rutsch et al 2009</a>], affecting the synthesis of the cofactors for the enzyme methylmalonyl-CoA mutase (encoded by <i>MMUT</i>) and the enzyme methyltetrahydrofolate: homocysteine methyltransferase, also known as methionine synthase (MS) (encoded by <i>MTR</i>).</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>cblJ</i> deficiency</b> caused by mutation of <i>ABCD4</i>, an ATP-binding cassette (ABC) transporter that affects the lysosomal release of Cbl into the cytoplasm similar to cblF and presents with hypotonia, lethargy, poor feeding, bone marrow suppression, macrocytic anemia, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease in some patients [<a class="bk_pop" href="#mma.REF.coelho.2012.1152">Coelho et al 2012</a>].</div><div class="half_rhythm">It is important to note that several individuals with <i>cblF or cblJ</i> can have decreased serum vitamin B<sub>12</sub> levels, suggesting a role for the lysosome in intestinal uptake of ingested cobalamin.</div></li><li class="half_rhythm"><div class="half_rhythm"><b><i>cblX</i> deficiency</b> is caused by mutation of the <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>HCFC1</i>, a transcriptional co-regulator affecting the expression of <i>MMACHC</i>. All described <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males to date had MMAemia and MMAuria, and most, when studied, displayed combined hyperhomocystinuria and methylmalonic acidemia. The clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> features intractable epilepsy and profound neurocognitive impairment without the specific bull's-eye maculopathy of <i>cblC</i> deficiency [<a class="bk_pop" href="#mma.REF.yu.2013.506">Yu et al 2013</a>]; however, the phenotype needs further characterization.</div></li></ul></li></ul><p><b>Vitamin B<sub>12</sub> deficiency.</b> Individuals with vitamin B<sub>12</sub> deficiency can have methylmalonic acidemia and homocystinuria.</p><p>Maternal B<sub>12</sub> deficiency can produce a methylmalonic acidemia syndrome in an infant that ranges from severe encephalopathy to elevated serum concentration of propionylcarnitine (C3) detected by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> [<a class="bk_pop" href="#mma.REF.chace.2001.2040">Chace et al 2001</a>]. This metabolic abnormality can occur in a breastfed infant of a vegan mother, in an infant born to a mother with subclinical pernicious anemia [<a class="bk_pop" href="#mma.REF.marble.2008.731">Marble et al 2008</a>], and in infants born to mothers who have had gastric surgery [<a class="bk_pop" href="#mma.REF.grange.1994.311">Grange &#x00026; Finlay 1994</a>, <a class="bk_pop" href="#mma.REF.celiker.2009.640">Celiker &#x00026; Chawla 2009</a>]. The mother does not necessarily have a very low serum concentration of vitamin B<sub>12</sub>. Intramuscular vitamin B<sub>12</sub> replacement therapy to normalize vitamin B<sub>12</sub> serum concentration reverses the metabolic abnormality.</p><p><b>Mitochondrial encephalomyopathy with elevated methylmalonic acid.</b> Mild methylmalonic aciduria has been described in succinate-ligase alpha subunit (caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SUCLG1</i> pathogenic variants) and succinate-ligase ADP-forming beta subunit (caused by biallelic <i>SUCLA2</i> pathogenic variants) associated with mitochondrial DNA depletion presenting with severe lactic acidosis and encephalomyopathy.</p><p>Succinyl-CoA ligase (SUCL) catalyzes the reversible conversion of succinyl-CoA and ADP or GDP to succinate and ATP or GTP, and comprises an &#x003b1; subunit encoded by <i>SUCLG1</i> and a &#x003b2; subunit encoded by either <i>SUCLA2</i> or <i>SUCLG2</i>.</p><p>Biallelic pathogenic variants in <i>SUCLG1</i> result in a severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, associated with lactic acidosis and early death in the first week of life. (See <a href="/books/n/gene/suclg1-mtddepl/"><i>SUCLG1</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a>.)</p><p>Biallelic <i>SUCLA2</i> pathogenic variants are associated with hypotonia, muscle atrophy presenting around ages three to six months (with mtDNA depletion, complex I, III, and IV deficiency in the muscle), hyperkinesia, seizures, severe hearing impairment, and growth failure. Patients develop a Leigh syndrome-like disorder, cortical and basal ganglia atrophy, and dystonia. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals die in infancy; others have survived into their 20s. (See <a href="/books/n/gene/sucla2-def/"><i>SUCLA2</i>-Related mtDNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a>.)</p><p>Methylmalonic aciduria ranges from 10 to 200 mmol/mol creatinine in these individuals and is accompanied by raised plasma concentrations of lactate, methylcitrate, 3-hydroxyproprionic and 3-hydroxyisovaleric acid, proprionylcarnitine, and C4-dicarboxylic carnitine (C4DC) [<a class="bk_pop" href="#mma.REF.elpeleg.2005.1081">Elpeleg et al 2005</a>, <a class="bk_pop" href="#mma.REF.carrozzo.2007.862">Carrozzo et al 2007</a>, <a class="bk_pop" href="#mma.REF.ostergaard.2007.853">Ostergaard et al 2007</a>, <a class="bk_pop" href="#mma.REF.morava.2009.438">Morava et al 2009</a>].</p><p><b>Reye-like syndrome.</b> A Reye-like syndrome of hepatomegaly and obtundation in the face of a mild intercurrent infection can be seen as an unrecognized presentation of a number of inborn errors of metabolism, including <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia [<a class="bk_pop" href="#mma.REF.chang.2000.295">Chang et al 2000</a>].</p><p><b>Other entities</b> that can display methylmalonic acidemia despite normal methylmalonyl-CoA mutase enzyme activity include the following:</p><ul><li class="half_rhythm"><div>"Atypical" methylmalonic acidemia with progressive neurodegenerative disease, microcephaly, and cataracts (2 sibs) [<a class="bk_pop" href="#mma.REF.str_mme.1995.1">Str&#x000f8;mme et al 1995</a>] or with a mitochondrial depletion syndrome/complex IV deficiency and combined propionic and methylmalonic acidemia (1 person) [<a class="bk_pop" href="#mma.REF.yano.2003.481">Yano et al 2003</a>]. These cases have similarities with the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> caused by mutation of <i>SUCLA2</i>.</div></li><li class="half_rhythm"><div>Benign methylmalonic acidemia with distal renal tubular acidosis (one sibship) [<a class="bk_pop" href="#mma.REF.dudley.1998.564">Dudley et al 1998</a>]</div></li><li class="half_rhythm"><div>Malonyl-CoA decarboxylase deficiency, usually associated with combined methylmalonic and malonic aciduria, with significantly higher malonic versus methylmalonic acid levels [<a class="bk_pop" href="#mma.REF.brown.1984.21">Brown et al 1984</a>]</div></li><li class="half_rhythm"><div>Isolated methylmalonic aciduria and normal plasma concentrations of methylmalonic acidemia (2 families) [<a class="bk_pop" href="#mma.REF.sewell.1996.203">Sewell et al 1996</a>, <a class="bk_pop" href="#mma.REF.martens.2002.219">Martens et al 2002</a>]</div></li></ul></div><div id="mma.Management"><h2 id="_mma_Management_">Management</h2><div id="mma.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>A serum chemistry panel (Na<sup>+</sup>, K<sup>+</sup>, CI<sup>&#x02013;</sup>, glucose, urea, creatinine, bicarbonate, AST, ALT, alkaline phosphatase, bilirubin [T/U], triglycerides, and cholesterol); complete blood count with differential; arterial or venous blood gas; plasma ammonium and lactic acid concentration; formal urinalysis and ketone measurement; quantitative plasma amino acids; and urine organic acid analysis by gas chromatography and mass spectrometry (GC-MS)</div></li><li class="half_rhythm"><div>If possible, measurement of plasma concentrations of methylmalonic acid, methylcitrate, free and total carnitine, and an acylcarnitine profile to document propionylcarnitine (C3 species) concentration</div></li><li class="half_rhythm"><div>Measurement of serum vitamin B<sub>12</sub> concentration to determine if a nutritional deficiency is present in the patient and possibly the mother (in newborns)</div></li><li class="half_rhythm"><div>Biochemical genetics consultation</div></li></ul></div><div id="mma.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No consensus exists among various metabolic centers regarding treatment of acute and chronic complications of methylmalonic acidemia. Recent guidelines developed by professionals across 12 European countries and the US based on rigorous literature evaluation and expert group meetings outline the current management recommendations and areas for further research [<a class="bk_pop" href="#mma.REF.baumgartner.2014.130">Baumgartner et al 2014</a>].</p><p><b>Stabilization of critically ill individuals</b></p><ul><li class="half_rhythm"><div>Volume replacement with isotonic solutions</div></li><li class="half_rhythm"><div>All IV solutions should contain glucose, preferably D<sub>10</sub> or D<sub>12.5</sub>. If hyperglycemia develops, an insulin infusion may be needed.</div></li><li class="half_rhythm"><div>The total base deficit should be followed serially with repeat electrolyte and venous or arterial blood gas measurements and corrected by hydration and bicarbonate replacement, as needed [<a class="bk_pop" href="#mma.REF.baumgartner.2014.130">Baumgartner et al 2014</a>]. Adequate kcals must be delivered. Central or peripheral total parenteral nutrition (TPN), which typically contains glucose and amino acids, and in some instances, lipids, may be required. Total protein administration is usually completely withdrawn for no more than 24-48 hours and reinstated gradually depending on the patient's acid-base balance and remaining test values, including ammonia, lactic acid, and plasma amino acids among others.</div></li><li class="half_rhythm"><div>Lipid infusions must be used with caution for the risk of pancreatitis.</div></li><li class="half_rhythm"><div>Carnitine may be administered intravenously at 50-100 mg/kg/d bid-qid.</div></li><li class="half_rhythm"><div>Urine output and serum sodium and potassium concentration need to be monitored.</div></li><li class="half_rhythm"><div>Dietary protein should be reintroduced enterally as soon as is feasible given the clinical scenario and may need to be further augmented with TPN. Nasograstric or orogastric feeding should be strongly considered so that enteral feedings can be reintroduced without delay.</div></li><li class="half_rhythm"><div>N-carbamylglutamate (NCG, Carbaglu<sup>&#x000ae;</sup>) may be considered in the event of hyperammonemia. NCG allosterically activates CPS1 (carbamyl phosphate synthetase 1), the first step of the urea cycle. It has been effective in normalizing the blood ammonia concentration in patients with a deficiency of NAGS (N-acetylglutamate synthase) and can also benefit some patients with propionic and possibly methylmalonic acidemia [<a class="bk_pop" href="#mma.REF.tuchman.2008.213">Tuchman et al 2008</a>, <a class="bk_pop" href="#mma.REF.ah_mew.2010.e208">Ah Mew et al 2010</a>].</div></li><li class="half_rhythm"><div>Hemodialysis or hemofiltration may be required in the event of treatment failure (uncontrollable acidosis and/or hyperammonemia).</div></li></ul><p>A letter given to the family to present to emergency department physicians that specifies the recommended acute management protocol should be standard of care.</p><p>Medic Alert<sup>&#x000ae;</sup> bracelets and emergency treatment protocols outlining fluid and electrolyte therapy should be available for all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b>Other</b></p><p>Aside from episodes of critical illness, patients with intercurrent illness such as viral infection or those undergoing surgery for various reasons should have aggressive fluid, metabolic, and nutritional management.</p><p>Specialists in physiatry, physical therapy, and occupational therapy can help address the complex challenges faced by patients and families, maximize functionality, and improve quality of life [<a class="bk_pop" href="#mma.REF.ktena.2015b.847">Ktena et al 2015b</a>].</p><p>Special considerations regarding choices of anesthetic agents in this patient population may apply [<a class="bk_pop" href="#mma.REF.ktena.2015a.2075">Ktena et al 2015a</a>, <a class="bk_pop" href="#mma.REF.ruzkova.2015.807">Ruzkova et al 2015</a>].</p><p>Most individuals require "sick day" management regimens, which typically consist of reducing or eliminating protein intake and increasing fluids and glucose to ensure delivery of adequate calories and to arrest lipolysis. Immediate hospitalization is usually required if signs suggest intercurrent infection.</p><p>Although all of the treatments discussed above may be needed in fragile individuals, they still may not prevent death, the severe sequelae of metabolic decompensation (e.g., metabolic stroke of the basal ganglia), or renal disease. The correlation and identification of treatment patterns and outcomes is needed to develop more effective management protocols for individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia.</p><p>Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals require gastrostomy/gastrojejunostomy tube feeding because of anorexia and vomiting to ensure caloric and fluid intake and improve growth.</p><p>Bone marrow failure during episodes of metabolic decompensation on rare occasion requires granulocyte-colony stimulating factor (GCSF).</p><p>Anemia is an expected complication of chronic renal failure and is treated with erythropoietin and eventually renal transplantation [<a class="bk_pop" href="#mma.REF.inoue.1981.95">Inoue et al 1981</a>, <a class="bk_pop" href="#mma.REF.guerramoreno.2003.17">Guerra-Moreno et al 2003</a>, <a class="bk_pop" href="#mma.REF.macfarland.2015.1840">MacFarland &#x00026; Hartung 2015</a>].</p><p>Some children have had documented growth hormone (GH) deficiency; however, because response to GH therapy may vary, diet and GH replacement dose need to be carefully adjusted [<a class="bk_pop" href="#mma.REF.bain.1995.850">Bain et al 1995</a>, <a class="bk_pop" href="#mma.REF.alowain.2004.239">Al-Owain et al 2004</a>]. The indications for GH replacement therapy and the response to GH replacement in treated individuals require further investigation.</p></div><div id="mma.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><div id="mma.Dietary_Management"><h4>Dietary Management</h4><p><b>Nutrition.</b> After stabilization, nutritional management is critical. This typically includes instituting a low-protein, high-calorie diet. When available, accurate assessment of resting energy expenditure can guide dietary and caloric prescriptions and eliminate overfeeding [<a class="bk_pop" href="#mma.REF.hauser.2011.47">Hauser et al 2011</a>].</p><p>Natural protein needs to be carefully titrated to allow for normal growth, while avoiding an excessive propiogenic amino acid load (isoleucine, valine, methionine, and threonine) into the pathway. Adjustment of dietary whole (complete)-protein intake, based on clinical and laboratory findings, is needed throughout life for these patients.</p><p>The <a href="http://apps.who.int/iris/bitstream/10665/43411/1/WHO_TRS_935_eng.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FAO/WHO/UNU report</a> [2007] recommended that safe levels per age group should be the aim for natural protein intake [<a class="bk_pop" href="#mma.REF.baumgartner.2014.130">Baumgartner et al 2014</a>]; however, the individual protein amount prescribed will depend on growth parameters, metabolic stability, stage of renal failure, and other factors. A propiogenic amino acid-deficient formula (e.g., Propimex<sup>&#x000ae;</sup>-1/2,<sup>,</sup> XMTVI-1/2, OA-1/2) and protein-free formula (e.g., Pro-Phree<sup>&#x000ae;</sup>, Duocal<sup>&#x000ae;</sup>) are given to some individuals to provide extra fluid and calories. As the infant grows, the total protein load is slowly reduced, based on growth, plasma amino acid concentrations, and plasma and urine methylmalonic acid concentrations.</p><p>Of note, in patients with low protein tolerance, severe restriction of propiogenic amino acid precursors (isoleucine, valine, methionine, and threonine) can produce a nutritional deficiency state. Furthermore, an iatrogenic essential amino acid deficiency can be induced by the relatively high leucine intake through the MMA formulas that can negatively affect long-term growth and possibly other outcomes [<a class="bk_pop" href="#mma.REF.manoli.2016b.386">Manoli et al 2016b</a>]. Medical foods should be used in moderation with the relative intake of natural protein to propiogenic amino-acid deficient formula not exceeding a ratio of 1:1. Isolated valine or isoleucine supplementation should be avoided.</p><p>These dietary guidelines do not apply for patients with <a href="/books/n/gene/cbl/"><i>CblC</i> deficiency</a>, a separate disorder in the pathway [<a class="bk_pop" href="#mma.REF.manoli.2016a.396">Manoli et al 2016a</a>].</p><p><b>Hydroxocobalamin injections.</b> 1.0-mg injections every day to every other day are usually required in individuals who are vitamin B<sub>12</sub> responsive. The regimen of B<sub>12</sub> injections needs to be individually adjusted according to the patient's age and, possibly, weight.</p><p><b>Carnitine</b> can be given at a dose of 50-100 mg/kg/day, up to approximately 300 mg/kg/day. As a dietary supplement, carnitine may replace the free carnitine pool and enhance the conjugation and excretion of propionylcarnitine. The contribution of propionylcarnitine excretion to the total propionate load is, however, small. The relief of intracellular CoA accretion may be the mechanism by which carnitine supplementation benefits some individuals.</p><p><b>Antibiotics.</b> A variety of antibiotic regimens to reduce the production of propionate from gut flora can be used:</p><ul><li class="half_rhythm"><div>Oral neomycin, 250 mg by mouth 4x/day, was the original regimen reported by <a class="bk_pop" href="#mma.REF.snyderman.1972.925">Snyderman et al [1972]</a>.</div></li><li class="half_rhythm"><div>Metronidazole at 10-15 mg/kg/day has also been reported.</div></li></ul><p>The intervals at which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are treated may vary, but a typical course is one week to ten days of treatment per one to three months.</p><p>Although oral antibiotics reduce the propionate load that derives from gut flora in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, chronic antibiotic therapy is not innocuous; it introduces the risk of repopulation of the individual with resistant flora. This could pose a serious infectious threat and could be especially dangerous to individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia, since most deaths are related to metabolic decompensation, often precipitated by infection.</p><p>Response to antibiotic administration should be determined in treated persons by demonstrating either a decrease in whole body output of methylmalonic acid on antibiotic therapy by a timed urine collection or a decrease in the plasma methylmalonic acid concentration compared to the baseline value for that individual.</p><p>Rotating antibiotic regimens may be considered in some persons.</p><p><b>Antioxidants.</b> One individual with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia who was documented to be glutathione deficient after a severe metabolic crisis responded to ascorbate therapy [<a class="bk_pop" href="#mma.REF.treacy.1996.445">Treacy et al 1996</a>]. Several recent studies document increased oxidative stress, glutathione depletion, and specific respiratory chain complex deficiencies in persons with the <i>mut<sup>0</sup></i> enzymatic subtype with methylmalonic acidemia [<a class="bk_pop" href="#mma.REF.schwab.2006.107">Schwab et al 2006</a>, <a class="bk_pop" href="#mma.REF.atkuri.2009.3941">Atkuri et al 2009</a>, <a class="bk_pop" href="#mma.REF.chandler.2009.1252">Chandler et al 2009</a>, <a class="bk_pop" href="#mma.REF.de_keyzer.2009.91">de Keyzer et al 2009</a>, <a class="bk_pop" href="#mma.REF.manoli.2013.13552">Manoli et al 2013</a>], suggesting a potential benefit of treatment with antioxidants or other mitochondria-targeted therapies in these patients.</p><p>A regimen of coenzyme Q<sub>10</sub> and vitamin E has been shown to prevent progression of acute optic nerve involvement in a patient with MMA [<a class="bk_pop" href="#mma.REF.pinarsueiro.2010.s199">Pinar-Sueiro et al 2010</a>] and was shown to attenuate the progression of kidney disease in a mouse model of MMA [<a class="bk_pop" href="#mma.REF.manoli.2013.13552">Manoli et al 2013</a>].</p></div><div id="mma.Organ_Transplantation"><h4>Organ Transplantation</h4><p>The number of individuals who have undergone liver and/or kidney transplantation, the detailed effects on the underlying metabolic disorder, and the overall outcome in those undergoing this procedure have yet to be determined [<a class="bk_pop" href="#mma.REF.sloan.2015.1346">Sloan et al 2015</a>]. Inclusion of enzymatic and <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> information in case series of transplanted patients will allow better comparisons of the outcomes and genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associations that could inform decisions about the indication and timing of transplantation in individual cases.</p><p><b>Liver transplantation</b>. Because most of the metabolic conversion of propionate occurs in the liver, replacing the liver could contribute enough enzyme activity to avert metabolic decompensation. Liver transplantation has been shown to largely protect against metabolic instability but is not curative, and individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> MMA remain at risk for long-term complications of MMA including renal disease, basal ganglia injury, and neurologic complications [<a class="bk_pop" href="#mma.REF.chakrapani.2002.261">Chakrapani et al 2002</a>, <a class="bk_pop" href="#mma.REF.nyhan.2002.377">Nyhan et al 2002</a>, <a class="bk_pop" href="#mma.REF.kaplan.2006.322">Kaplan et al 2006</a>, <a class="bk_pop" href="#mma.REF.vernon.2014.899">Vernon et al 2014</a>]. To date, more than 35 individuals with isolated methylmalonic acidemia have undergone living donor or cadaveric, orthotopic, or partial liver transplantation or combined liver-kidney transplantation (&#x0003e;20 patients) [van't Hoff et al 1998, <a class="bk_pop" href="#mma.REF.vant_hoff.1999.s70">van't Hoff, McKiernan et al 1999</a>, <a class="bk_pop" href="#mma.REF.kayler.2002.295">Kayler et al 2002</a>, <a class="bk_pop" href="#mma.REF.nyhan.2002.377">Nyhan et al 2002</a>, <a class="bk_pop" href="#mma.REF.hsui.2003.171">Hsui et al 2003</a>, <a class="bk_pop" href="#mma.REF.kasahara.2006.943">Kasahara et al 2006</a>, <a class="bk_pop" href="#mma.REF.morioka.2007.2782">Morioka et al 2007</a>, <a class="bk_pop" href="#mma.REF.mcguire.2011.e142">McGuire et al 2011</a>, <a class="bk_pop" href="#mma.REF.niemi.2015.1455">Niemi et al 2015</a>].</p><ul><li class="half_rhythm"><div>The underlying biochemical parameters and the frequency of metabolic decompensation improved significantly in individuals undergoing liver transplantation despite persistent metabolic abnormalities [<a class="bk_pop" href="#mma.REF.nyhan.2002.377">Nyhan et al 2002</a>, <a class="bk_pop" href="#mma.REF.kaplan.2006.322">Kaplan et al 2006</a>, <a class="bk_pop" href="#mma.REF.niemi.2015.1455">Niemi et al 2015</a>], probably as a result of increased extrahepatorenal methylmalonic acid production primarily from the skeletal muscle [<a class="bk_pop" href="#mma.REF.chandler.2007.64">Chandler et al 2007</a>].</div></li><li class="half_rhythm"><div>Following liver transplantation, some individuals continued to have progressive renal failure as well as high CSF concentrations of methylmalonic acid [<a class="bk_pop" href="#mma.REF.nyhan.2002.377">Nyhan et al 2002</a>, <a class="bk_pop" href="#mma.REF.kaplan.2006.322">Kaplan et al 2006</a>].</div><ul><li class="half_rhythm"><div class="half_rhythm">Neurologic complications post-transplant, including globus pallidus injuries [<a class="bk_pop" href="#mma.REF.chakrapani.2002.261">Chakrapani et al 2002</a>, <a class="bk_pop" href="#mma.REF.cosson.2008.107">Cosson et al 2008</a>, <a class="bk_pop" href="#mma.REF.mcguire.2011.e142">McGuire et al 2011</a>] suggest that adequate protein restriction and supportive care should be continued after the transplantation.</div><div class="half_rhythm">Earlier transplantation particularly for individuals with <i>mut<sup>0</sup></i> (who are very fragile) is gaining support as surgery techniques and outcomes improve [<a class="bk_pop" href="#mma.REF.niemi.2015.1455">Niemi et al 2015</a>, <a class="bk_pop" href="#mma.REF.spada.2015.1173">Spada et al 2015</a>]. The choice of the kind and timing of the indicated transplant procedure remains challenging for families and treating physicians [<a class="bk_pop" href="#mma.REF.sloan.2015.1346">Sloan et al 2015</a>]. In the long term, the details regarding development of renal disease, optic nerve atrophy, and neurologic complications will be most important.</div></li></ul></li></ul><p><b>Kidney transplantation</b>. Some individuals have received only renal allografts [<a class="bk_pop" href="#mma.REF.van_calcar.1998.729">Van Calcar et al 1998</a>, <a class="bk_pop" href="#mma.REF.lubrano.2001.848">Lubrano et al 2001</a>, <a class="bk_pop" href="#mma.REF.coman.2006.270">Coman et al 2006</a>, <a class="bk_pop" href="#mma.REF.cosson.2008.107">Cosson et al 2008</a>, <a class="bk_pop" href="#mma.REF.clothier.2011.695">Clothier et al 2011</a>].</p><p>One of the first reports on <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> renal transplantation in <i>mut<sup>0</sup></i> methylmalonic acidemia was claimed to provide enough enzyme activity to normalize methylmalonic acid excretion and allow for increased dietary protein tolerance; however, it was later determined that that patient had <i>cblA</i> deficiency and responded to vitamin B<sub>12</sub>. Thus, this individual, who has a much milder case, is not representative of the outcomes of isolated renal transplantation in individuals with severe MMA subtypes (<i>mut<sup>0</sup></i> or <i>cblB</i>) [<a class="bk_pop" href="#mma.REF.lubrano.2001.848">Lubrano et al 2001</a>, <a class="bk_pop" href="#mma.REF.lubrano.2007.1209">Lubrano et al 2007</a>, <a class="bk_pop" href="#mma.REF.lubrano.2013.2067">Lubrano et al 2013</a>].</p><p>Elective kidney transplantation, even before the onset of renal disease, has been advocated as a form of "cell therapy" to help stabilize individuals with <i>mut<sup>0</sup></i> MMA [<a class="bk_pop" href="#mma.REF.brassier.2013.106">Brassier et al 2013</a>]. However, one patient died after developing hepatoblastoma, neurologic deterioration accompanied by CSF lactic acidosis, and multiorgan failure; a second patient developed progressive neurologic symptoms; and two others developed metabolic decompensations post transplant. Long-term follow up is necessary to determine if this is a safe alternative to liver transplantation or liver-kidney transplantation, especially in persons with severe <i>mut<sup>0</sup></i> MMA.</p></div></div><div id="mma.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Frequent monitoring of plasma amino acids is necessary to avoid deficiencies of essential amino acids (particularly isoleucine, valine, and methionine) as a result of excessive protein restriction and the development of acrodermatitis-enteropathica-like cutaneous lesions in methylmalonic aciduria, as in other organic acidurias (glutaric aciduria-I) and amino acid disorders (<a href="/books/n/gene/msud/">maple syrup urine disease</a>) [<a class="bk_pop" href="#mma.REF.de_raeve.1994.416">De Raeve et al 1994</a>].</p><p>Low plasma amino acids can reflect low natural protein intake, imbalanced intake of branched chain amino acid from use of metabolic formulas, or effects of chronic acidosis on branched chain amino acid metabolism [<a class="bk_pop" href="#mma.REF.manoli.2016b.386">Manoli et al 2016b</a>].</p></div><div id="mma.Surveillance"><h3>Surveillance</h3><p>During the first year of life, infants may need to be evaluated as frequently as every week. No guidelines regarding the recommended type or frequency of laboratory testing have been published.</p><p>The following should be monitored on a regular six-month to one-year basis or more frequently if the patient is unstable and requires frequent changes in management:</p><ul><li class="half_rhythm"><div>Plasma amino acids</div></li><li class="half_rhythm"><div>Plasma and urine MMA levels</div></li><li class="half_rhythm"><div>Serum acylcarnitines and free and total carnitine levels</div></li><li class="half_rhythm"><div>Chemistry: Na+, K+, CI&#x02013;, glucose, urea, creatinine, bicarbonate, AST, ALT, alkaline phosphatase, bilirubin (T/U), triglycerides, and cholesterol</div></li><li class="half_rhythm"><div>Liver, kidney, and bone health</div></li><li class="half_rhythm"><div>Bone marrow indices</div></li></ul><p>Monitoring of kidney function periodically with creatinine, cystatin-C, and, if available, studies of glomerular filtration rate (GFR) (e.g., iohexol plasma decay), in addition to imaging of the kidneys, will allow for early referral to nephrology and appropriate timing of renal transplantation when needed [<a class="bk_pop" href="#mma.REF.vant_hoff.1999.s70">van't Hoff et al 1999</a>, <a class="bk_pop" href="#mma.REF.kruszka.2013.990">Kruszka et al 2013</a>]. Combined equations based on creatinine and cystatin-C are expected to reflect more accurately the kidney function in this patient population [<a class="bk_pop" href="#mma.REF.schwartz.2009.629">Schwartz et al 2009</a>].</p><p>Regular ophthalmology and audiology evaluations to screen for optic nerve thinning/pallor and hearing loss [Authors, unpublished observations] are recommended.</p></div><div id="mma.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Fasting. During acute illness, intake of adequate calories is necessary to arrest/prevent decompensation.</div></li><li class="half_rhythm"><div>Stress</div></li><li class="half_rhythm"><div>Increased dietary protein</div></li><li class="half_rhythm"><div>Supplementation with the individual propiogenic amino acids valine and isoleucine, as they directly increase the toxic metabolite load in patients with disordered propionate oxidation [<a class="bk_pop" href="#mma.REF.nyhan.1973.539">Nyhan et al 1973</a>, <a class="bk_pop" href="#mma.REF.hauser.2011.47">Hauser et al 2011</a>, <a class="bk_pop" href="#mma.REF.manoli.2016b.386">Manoli et al 2016b</a>]</div></li></ul></div><div id="mma.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Depending on the <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, evaluation of sibs at risk should be performed using biochemical testing with treatment instituted as soon as possible if a sib is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Molecular genetic testing (if the pathogenic variants in the family are known) or cellular enzymology typically can further confirm the results of biochemical studies. Prenatal diagnosis of at-risk sibs may allow for prompt treatment of affected newborns at the time of delivery.</p><p>See <a href="#mma.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="mma.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Oral and intramuscular vitamin B<sub>12</sub> has been administered to women pregnant with a fetus with vitamin B<sub>12</sub>-responsive MMA, resulting in decreased maternal MMA urine output [<a class="bk_pop" href="#mma.REF.ampola.1975.313">Ampola et al 1975</a>, <a class="bk_pop" href="#mma.REF.van_der_meer.1990.923">van der Meer et al 1990</a>]. Despite these observations, maternal vitamin B<sub>12</sub> supplementation for <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> MMA needs further study.</p><p>Despite high maternal MMA levels, fetal growth and development were normal for all reported pregnancies of women with MMA [<a class="bk_pop" href="#mma.REF.wasserstein.1999.788">Wasserstein et al 1999</a>, <a class="bk_pop" href="#mma.REF.deodato.2002.133">Deodato et al 2002</a>].</p><p>Complications observed in pregnancies of women with MMA can include acute decompensation or hyperammonemia, deterioration of renal function, and obstetric complications including preeclampsia, preterm delivery, and cesarean section [<a class="bk_pop" href="#mma.REF.raval.2015.839">Raval et al 2015</a>].</p></div><div id="mma.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Carefully designed clinical studies are required to evaluate the efficacy of antioxidant regimens in patients with MMA.</p><p><b>Gene therapy.</b> Preliminary studies in human-derived hepatocytes and animal models of methylmalonic acidemia suggest a potential benefit of <a class="def" href="/books/n/gene/glossary/def-item/gene-therapy/">gene therapy</a> [<a class="bk_pop" href="#mma.REF.chandler.2008.53">Chandler &#x00026; Venditti 2008</a>, <a class="bk_pop" href="#mma.REF.carrillocarrasco.2010.1147">Carrillo-Carrasco et al 2010</a>, <a class="bk_pop" href="#mma.REF.chandler.2010.11">Chandler &#x00026; Venditti 2010</a>, <a class="bk_pop" href="#mma.REF.chandler.2012.617">Chandler &#x00026; Venditti 2012</a>, <a class="bk_pop" href="#mma.REF.s_nac.2012.385">S&#x000e9;nac et al 2012</a>]. The effect of that therapeutic approach in patients and especially on the long-term complications of methylmalonic acidemia remains to be elucidated in appropriate clinical studies.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="mma.Genetic_Counseling"><h2 id="_mma_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mma.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Isolated methylmalonic acidemia (complete or partial deficiency of the enzyme methylmalonyl-CoA mutase; defect in transport or synthesis of the methylmalonyl-CoA mutase cofactor, adenosyl-cobalamin; and deficiency of the enzyme methylmalonyl-CoA epimerase) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="mma.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes and therefore carry one <i>MMUT</i>, <i>MMAA</i>, <i>MMAB</i>, <i>MCEE</i>, or <i>MMADHC</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each full sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MMUT</i>, <i>MMAA</i>, <i>MMAB, MCEE</i>, or <i>MMADHC</i>.</p><p><b>Other family members.</b> Each full sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MMUT</i>, <i>MMAA</i>, <i>MMAB</i>, <i>MCEE</i>, or <i>MMADHC</i>.</p></div><div id="mma.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>MMUT</i>, <i>MMAA</i>, <i>MMAB</i>, <i>MCEE</i>, or <i>MMADHC</i> pathogenic variants in the family.</p><p>Methods other than <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> are not reliable for <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a>.</p></div><div id="mma.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#mma.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on testing at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="mma.Prenatal_Testing"><h3>Prenatal Testing</h3><p>Prenatal testing for pregnancies at 25% risk for <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia is possible by:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Molecular genetic testing</b> if the <i>MMUT</i>, <i>MMAA</i>, <i>MMAB</i>, <i>MCEE</i>, or <i>MMADHC</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div><div class="half_rhythm">Note: Due to the limited availability and longer turnaround time for cellular biochemical assays, the preferred method for <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> is <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div class="half_rhythm">The use of fetal cell-free DNA in maternal plasma [<a class="bk_pop" href="#mma.REF.gu.2014.564">Gu et al 2014</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Biochemical testing.</b> Historically both amniotic fluid measurements and cellular biochemical assays were used:</div><ul><li class="half_rhythm"><div class="half_rhythm">Amniotic fluid analysis of methylmalonic acid. The absolute positive predictive and negative predictive values of metabolite analysis only have yet to be determined. Elevation of metabolites below the range of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetuses can indicate a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> status and should therefore be followed by confirmatory testing in cell studies.</div></li><li class="half_rhythm"><div class="half_rhythm">Incorporation of <sup>14</sup>C propionate and complementation assay of cultured fetal cells obtained by amniocentesis usually performed at approximately 15 to 18 weeks' gestation or chorionic villus sampling (CVS) at approximately ten to 12 weeks' gestation. Studies on chorionic villus cells can be false negative and should be followed up by studies on cultured amniocytes [<a class="bk_pop" href="#mma.REF.morel.2005.160">Morel et al 2005</a>]. Confirmation of the diagnosis by the same assay in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member must be obtained before prenatal testing can be performed.</div><div class="half_rhythm">Note: For pregnant women not interested in pursuing <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> by amniocentesis or CVS, a urine organic acid test may be helpful since women carrying an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus have been shown to excrete MMA in their urine [<a class="bk_pop" href="#mma.REF.ampola.1975.313">Ampola et al 1975</a>, <a class="bk_pop" href="#mma.REF.van_der_meer.1990.923">van der Meer et al 1990</a>].</div></li></ul></li></ul><p><b>Preimplantation genetic diagnosis (PGD)</b> may be an option for families in which the <i>MMUT</i>, <i>MMAA</i>, <i>MMAB</i>, <i>MCEE</i>, or <i>MMADHC</i> pathogenic variants have been identified.</p></div></div><div id="mma.Resources"><h2 id="_mma_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Methylmalonic%20acidemia&#x00026;parent=Metabolic%20Disorders&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methylmalonic acidemia</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/methylmalonic-acidemia" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methylmalonic acidemia</a></div></li><li class="half_rhythm"><div><b>Save Babies Through Screening Foundation, Inc.</b></div><div>P. O. Box 42197</div><div>Cincinnati OH 45242</div><div><b>Phone:</b> 888-454-3383</div><div><b>Email:</b> email@savebabies.org</div><div><a href="http://www.savebabies.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.savebabies.org</a></div></li><li class="half_rhythm"><div><b>Organic Acidemia Association</b></div><div><b>Phone:</b> 763-559-1797</div><div><b>Fax:</b> 866-539-4060 (toll-free)</div><div><b>Email:</b> kstagni@oaanews.org; menta@oaanews.org</div><div><a href="http://www.oaanews.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.oaanews.org</a></div></li><li class="half_rhythm"><div><b>European Registry and Network for Intoxication Type Metabolic Diseases (E-IMD)</b></div><div><a href="https://www.e-imd.org/event/european-registry-and-network-intoxication-type-metabolic-diseases" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.e-imd.org/en/index.phtml</a></div></li></ul></div><div id="mma.Molecular_Genetics"><h2 id="_mma_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="mma.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Isolated Methylmalonic Acidemia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_mma.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_mma.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_mma.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_mma.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_mma.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_mma.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_mma.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84693" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MCEE</i></a></td><td headers="hd_b_mma.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84693" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96PE7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methylmalonyl-CoA epimerase, mitochondrial</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://lovd.nl/MCEE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MCEE)</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MCEE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MCEE</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MCEE[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MCEE</a></td></tr><tr><td headers="hd_b_mma.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/166785" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MMAA</i></a></td><td headers="hd_b_mma.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=166785" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">4q31<wbr style="display:inline-block"></wbr>​.21</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8IVH4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methylmalonic aciduria type A protein, mitochondrial</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://lovd.nl/MMAA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MMAA)</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MMAA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMAA</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MMAA[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMAA</a></td></tr><tr><td headers="hd_b_mma.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/326625" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MMAB</i></a></td><td headers="hd_b_mma.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=326625" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q24<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96EY8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Corrinoid adenosyltransferase</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://proteomics.bio21.unimelb.edu.au/lovd/genes/MMAB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMAB @ LOVD</a><br /><a href="https://lovd.nl/MMAB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MMAB)</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MMAB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMAB</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MMAB[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMAB</a></td></tr><tr><td headers="hd_b_mma.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/27249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MMADHC</i></a></td><td headers="hd_b_mma.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=27249" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q23<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9H3L0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methylmalonic aciduria and homocystinuria type D protein, mitochondrial</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://proteomics.bio21.unimelb.edu.au/lovd/genes/MMADHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMADHC @ LOVD</a><br /><a href="https://lovd.nl/MMADHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MMADHC)</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MMADHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMADHC</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MMADHC[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMADHC</a></td></tr><tr><td headers="hd_b_mma.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4594" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MMUT</i></a></td><td headers="hd_b_mma.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4594" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6p12<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P22033" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methylmalonyl-CoA mutase, mitochondrial</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://lovd.nl/MUT" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MUT)</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MMUT" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMUT</a></td><td headers="hd_b_mma.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MMUT[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMUT</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="mma.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="mma.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Isolated Methylmalonic Acidemia (<a href="/omim/251000,251100,251110,251120,277410,607481,607568,608419,609058,611935" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/251000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">251000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/251100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">251100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONIC ACIDURIA, cblA TYPE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/251110" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">251110</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONIC ACIDURIA, cblB TYPE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/251120" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">251120</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONYL-CoA EPIMERASE DEFICIENCY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/277410" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">277410</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607481" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607481</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MMAA GENE; MMAA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607568" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607568</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MMAB GENE; MMAB</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608419" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608419</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONYL-CoA EPIMERASE; MCEE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609058" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609058</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONYL-CoA MUTASE; MUT</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611935" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611935</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MMADHC GENE; MMADHC</td></tr></tbody></table></div></div><p><b><i>MMAA</i></b></p><p><b>Gene structure.</b>
<i>MMAA</i> comprises seven exons; the first is non-coding [<a class="bk_pop" href="#mma.REF.dobson.2002b.15554">Dobson et al 2002b</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1231/#mma.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 20 pathogenic variants have been described, including <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants, deletions, and insertions [<a class="bk_pop" href="#mma.REF.dobson.2002a.3361">Dobson et al 2002a</a>, <a class="bk_pop" href="#mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</a>, <a class="bk_pop" href="#mma.REF.yang.2004.329">Yang et al 2004</a>, <a class="bk_pop" href="#mma.REF.merinero.2008.55">Merinero et al 2008</a>].</p><div id="mma.T.mmaa_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>MMAA</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.T.mmaa_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.T.mmaa_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.64C&#x0003e;T</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg22Ter</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_3" rowspan="15" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/26892294" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_172250<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/26892295" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_758454<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.161G&#x0003e;A</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp54Ter</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.266T&#x0003e;C</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu89Pro</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.283C&#x0003e;T</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln95Ter</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.358C&#x0003e;T</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln120Ter</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.397C&#x0003e;T</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln133Ter</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.433C&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg145Ter&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.503delC&#x000a0;<sup>2</sup></td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr168MetfsTer9&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.562G&#x0003e;C</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly188Arg</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.650T&#x0003e;A</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu217Ter</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.653G&#x0003e;A</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly218Glu</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.733+1G&#x0003e;A</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.988C&#x0003e;T</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg330Ter</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1076G&#x0003e;A</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg359Gln</td></tr><tr><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.592_595delACTG</td><td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr198SerfsTer6</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="mma.TF.3.1"><p class="no_margin">The most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified; accounts for 43% of mutated alleles identified in one large study [<a class="bk_pop" href="#mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</a>]. This variant resides on a common haplotype and has also been seen in Spanish individuals [<a class="bk_pop" href="#mma.REF.mart_nez.2005.317">Mart&#x000ed;nez et al 2005</a>].</p></div></dd><dt>2. </dt><dd><div id="mma.TF.3.2"><p class="no_margin">In Japan, a common pathogenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, c.503delC, has been observed [<a class="bk_pop" href="#mma.REF.yang.2004.329">Yang et al 2004</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gene is predicted to encode a protein of 418 amino acids. The predicted gene product possesses a mitochondrial leader sequence and appears to belong to the ArgK protein subfamily of G3E GTPases [<a class="bk_pop" href="#mma.REF.leipe.2002.41">Leipe et al 2002</a>]. While this protein was originally proposed to function in cobalamin entry into the mitochondria [<a class="bk_pop" href="#mma.REF.dobson.2002a.3361">Dobson et al 2002a</a>], it was recently characterized as a metallochaperone GTPase that acts to protect the methylmalonyl-CoA mutase enzyme from oxidative inactivation during catalytic cycles and to facilitate cofactor (adenosylcobalamin) binding [<a class="bk_pop" href="#mma.REF.korotkova.2004.13652">Korotkova &#x00026; Lidstrom 2004</a>, <a class="bk_pop" href="#mma.REF.hubbard.2007.31308">Hubbard et al 2007</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The precise biochemical function of the <i>MMAA</i> gene product is unknown but suspected to be similar to homologs in bacteria. Missense pathogenic variants appear to fall in evolutionarily conserved residues or consensus splice sites. Environmental, dietary, and (possibly) epigenetic modifiers may operate to define the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in this condition, especially since individuals with <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants can exhibit disparate phenotypes [<a class="bk_pop" href="#mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</a>].</p><p><b><i>MMAB</i></b></p><p><b>Gene structure.</b>
<i>MMAB</i> comprises nine exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1231/#mma.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Several <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>/frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> pathogenic variants have been identified [<a class="bk_pop" href="#mma.REF.dobson.2002a.3361">Dobson et al 2002a</a>, <a class="bk_pop" href="#mma.REF.yang.2004.329">Yang et al 2004</a>, <a class="bk_pop" href="#mma.REF.mart_nez.2005.317">Mart&#x000ed;nez et al 2005</a>, <a class="bk_pop" href="#mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</a>]. More than half occurred in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7 [<a class="bk_pop" href="#mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</a>]:</p><p>Two individuals of African American descent with a late presentation (ages 3 and 8 years) both had three <i>MMAB</i> pathogenic variants: c.403G&#x0003e;A, c.571C&#x0003e;T, and c.656A&#x0003e;G [<a class="bk_pop" href="#mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</a>].</p><div id="mma.T.mmab_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>MMAB</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.T.mmab_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.T.mmab_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.287T&#x0003e;C</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile96Thr</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/120432048" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NM_052845.3</u></a><br /><a href="/protein/16418349" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NP_443077.1</u></a></td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.291-1G&#x0003e;A</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.403G&#x0003e;A</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala135Thr</td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.556C&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg186Trp&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.568C&#x0003e;T</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg190Cys</td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.569G&#x0003e;A</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg190His</td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.571C&#x0003e;T</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg191Trp</td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.572G&#x0003e;A</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg191Gln</td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.656A&#x0003e;G</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr219Cys</td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.197-1G&#x0003e;T</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.700C&#x0003e;T</td><td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln234Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="mma.TF.4.1"><p class="no_margin">The most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a large series [<a class="bk_pop" href="#mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</a>], accounting for 33% of all alleles and seen exclusively among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of European descent, was associated with early onset of symptoms (age &#x0003c;1 year).</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The gene encodes the 250-amino-acid ATP-dependent mitochondrial protein cob(I)alamin adenosyltransferase, an enzyme that transfers the adenosyl group from ATP to Co[+1] balamin [<a class="bk_pop" href="#mma.REF.leal.2003.9227">Leal et al 2003</a>] to form adenosyslcobalamin and shuttles this cofactor to the MUT enzyme. The crystal structure of a bacterial homologue has been determined [<a class="bk_pop" href="#mma.REF.saridakis.2004.23646">Saridakis et al 2004</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The reported pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants fall into residues that are evolutionarily conserved [<a class="bk_pop" href="#mma.REF.dobson.2002b.15554">Dobson et al 2002b</a>]. One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> destroys a <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> [<a class="bk_pop" href="#mma.REF.dobson.2002b.15554">Dobson et al 2002b</a>, <a class="bk_pop" href="#mma.REF.mart_nez.2005.317">Mart&#x000ed;nez et al 2005</a>]. Several pathogenic variants have been biochemically characterized [<a class="bk_pop" href="#mma.REF.saridakis.2004.23646">Saridakis et al 2004</a>].</p><p><b><i>MMUT</i></b></p><p><b>Gene structure.</b>
<i>MMUT</i> comprises 13 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1231/#mma.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 190 pathogenic variants have been described, including 103 (54%) <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>; 27 (14%) <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>; 18 (9%) <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>; 42 (22%) small insertions/deletions; and one large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 12. The pathogenic variants are distributed throughout the entire coding sequence except for exon 1, which is untranslated [<a class="bk_pop" href="#mma.REF.crane.1992.385">Crane et al 1992</a>, <a class="bk_pop" href="#mma.REF.crane.1994.42">Crane &#x00026; Ledley 1994</a>, <a class="bk_pop" href="#mma.REF.ogasawara.1994.867">Ogasawara et al 1994</a>, <a class="bk_pop" href="#mma.REF.ledley.1997.1">Ledley &#x00026; Rosenblatt 1997</a>, <a class="bk_pop" href="#mma.REF.adjalla.1998.s248">Adjalla et al 1998</a>, <a class="bk_pop" href="#mma.REF.fuchshuber.2000.179">Fuchshuber et al 2000</a>, <a class="bk_pop" href="#mma.REF.acquaviva.2001.577">Acquaviva et al 2001</a>, <a class="bk_pop" href="#mma.REF.acquaviva.2005.167">Acquaviva et al 2005</a>, <a class="bk_pop" href="#mma.REF.jung.2005.367">Jung et al 2005</a>, <a class="bk_pop" href="#mma.REF.mart_nez.2005.317">Mart&#x000ed;nez et al 2005</a>, <a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al 2006</a>, <a class="bk_pop" href="#mma.REF.gradinger.2007.1045">Gradinger et al 2007</a>, <a class="bk_pop" href="#mma.REF.lempp.2007.284">Lempp et al 2007</a>, <a class="bk_pop" href="#mma.REF.sakamoto.2007.48">Sakamoto et al 2007</a>, <a class="bk_pop" href="#mma.REF.merinero.2008.55">Merinero et al 2008</a>].</p><p>For a list of pathogenic variants that have been repeatedly identified in diverse populations, click <a href="/books/NBK1231/bin/mma-MUTalleles.pdf">here</a> (pdf).</p><p>While some individuals are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a given <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, most are compound heterozygotes. The phenomenon of interallelic complementation makes prediction of <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>/enzyme activity difficult because some individuals who have two pathogenic variants can have a <i>mut<sup>&#x02013;</sup></i> enzymatic subtype in the compound state but a <i>mut<sup>0</sup></i> enzymatic subtype in the homozygous state [<a class="bk_pop" href="#mma.REF.janata.1997.1457">Janata et al 1997</a>, <a class="bk_pop" href="#mma.REF.ledley.1997.1">Ledley &#x00026; Rosenblatt 1997</a>, <a class="bk_pop" href="#mma.REF.acquaviva.2005.167">Acquaviva et al 2005</a>].</p><p>Persons with two truncating pathogenic variants usually have the <i>mut<sup>0</sup></i> enzymatic subtype.</p><p>Nonsense pathogenic variants have been described in the following codons: 7, 18, 23, 31, 54, 84, 117, 121, 135, 152, 156, 161, 224, 228, 284, 342, 403, 413, 414, 426, 429, 451, 467, 474, 494, 511, 544, 581, 589, 688, and 727.</p><p>Only a few of the frequently reported pathogenic variants are seen in <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> form; p.Arg108Cys, p.Asn219Tyr, and p.Arg369His cause a <i>mut<sup>0</sup></i> enzymatic subtype when homozygous [<a class="bk_pop" href="#mma.REF.acquaviva.2001.577">Acquaviva et al 2001</a>, <a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al 2006</a>], while p.Gly717Val and p.Arg694Trp are associated with a <i>mut<sup>&#x02013;</sup></i> enzymatic subtype when homozygous [<a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al 2006</a>].</p><p>One case of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 6 paternal isodisomy resulting in <i>mut<sup>0</sup></i> MMA and insulin-dependent diabetes mellitus has been reported [<a class="bk_pop" href="#mma.REF.abramowicz.1994.418">Abramowicz et al 1994</a>].</p><p>The <i>mut<sup>&#x02013;</sup></i> enzymatic subtype is known to be associated mostly, but not exclusively, with pathogenic variants in the cobalamin binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the <i>mut</i> protein. The <i>mut<sup>&#x02013;</sup></i> enzymatic subtype <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> plays usually a dominant role when in compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> state with a <i>mut<sup>0</sup></i> enzymatic subtype pathogenic variant, given a OH-Cbl response in the in vitro assay [<a class="bk_pop" href="#mma.REF.lempp.2007.284">Lempp et al 2007</a>].</p><div id="mma.T.mmut_pathogenic_missense_variants" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>MMUT</i> Pathogenic Missense Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.T.mmut_pathogenic_missense_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.T.mmut_pathogenic_missense_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mut Enzymatic Subtype (when Homozygous)</th><th id="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut<sup>0</sup></i></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.19C&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln7Ter</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_4" rowspan="27" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/4557766" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000255<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/4557767" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000246<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut<sup>0</sup></i></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.52C&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln18Ter</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut<sup>0</sup></i></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.91C&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg31Ter</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.278G&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg93His</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.284C&#x0003e;G</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro95Arg</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.313T&#x0003e;C</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp105Arg</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.322C&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg108Cys</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.521T&#x0003e;C</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe174Ser</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.572C&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala191Glu</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.607G&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly203Arg</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.643G&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly215Ser</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.655A&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn219Tyr</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.935G&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly312Val</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1105C&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg369Cys</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1106G&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg369His</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1280G&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly427Asp</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1867G&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly623Arg</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>&#x02013;</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.299A&#x0003e;G</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr100Cys</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>&#x02013;</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.691T&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr231Asn</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>&#x02013;</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1097A&#x0003e;G</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn366Ser</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1553T&#x0003e;C</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu518Pro</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1867G&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly623Arg</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut<sup>&#x02013;</sup></i>&#x000a0;<sup>2</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2054T&#x0003e;G</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu685Arg</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>&#x02013;</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2080C&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg694Trp</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>&#x02013;</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2099T&#x0003e;A</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met700Lys</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut<sup>&#x02013;</sup></i></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2150G&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly717Val</td></tr><tr><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>mut</i><sup>0</sup></td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2179C&#x0003e;T</td><td headers="hd_h_mma.T.mmut_pathogenic_missense_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg727Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>mut</i><sup>0</sup> = <i>mut</i><sup>0</sup> enzymatic subtype</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>mut</i><sup>&#x02013;</sup> = <i>mut</i><sup>&#x02013;</sup> enzymatic subtype</p></div></dd><dt></dt><dd><div><p class="no_margin">NA = not applicable</p></div></dd><dt>1. </dt><dd><div id="mma.TF.5.1"><p class="no_margin">Observed in individuals of Hispanic descent.</p></div></dd><dt>2. </dt><dd><div id="mma.TF.5.2"><p class="no_margin"><a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al [2006]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Methylmalonyl-CoA mutase enzyme, a nuclear-encoded enzyme localized in the mitochondria, exists as a homodimer. The protein comprises 750 amino acids and has an N-terminal mitochondrial leader sequence (residues 1-32) that is removed by the mitochondrial importation and processing machinery. The mitochondrial leader signal is followed by the N-terminal extended segment (residues 33-87), which is involved in subunit interaction. The N-terminal barrel is the substrate-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (residues 88-422) and is attached to the C-terminal adenosylcobalamin-binding domain (residues 578-750) by a long linker region (423-577). The protein contains a mole of adenosylcobalamin per mole of subunit and performs a 1, 2 rearrangement reaction, isomerizing L-methylmalonyl-CoA into succinyl-CoA [<a class="bk_pop" href="#mma.REF.fenton.2001">Fenton et al 2001</a>]. The crystal structure of the human enzyme has been solved [<a class="bk_pop" href="#mma.REF.froese.2013.1182">Froese et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Only selected pathogenic variants have been studied enzymatically. The methylmalonyl-CoA mutase protein has several functional domains; pathogenic variants have been described in each.</p><p>A mitochondrial leader sequence lies at the amino terminus. Three <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> pathogenic variants fall into this <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>: p.Gln7Ter [<a class="bk_pop" href="#mma.REF.acquaviva.2005.167">Acquaviva et al 2005</a>] and p.Gln18Ter and p.Arg31Ter [<a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al 2006</a>]. One report noted that a truncated protein, likely translated from an internal AUG, arose from the p.Gln18Ter variant. This mutated protein is "mis-targeted" and not functional.</p><p>The putative dimerization <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the enzyme subunits is adjacent to, but distinct from, the mitochondrial leader sequence.</p><p>The coenzyme-A binding pocket spans the middle of the second <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> to the end of the sixth exon. Pathogenic variants that reside in this location, between amino acids 86 and 423, may destroy substrate binding and are predicted to impede catalysis by a variety of mechanisms. Some, such as p.Arg93His, can participate in interallelic complementation. The mechanism underlying this phenomenon is unclear [<a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al 2006</a>].</p><p>A linker <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> spanning residues 424-577 separates the C-terminal cobalamin-binding domain. Most of the pathogenic variants identified in this domain are <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> changes and have been associated with <i>mut<sup>0</sup></i> enzymatic subtype of methylmalonic acidemia [<a class="bk_pop" href="#mma.REF.acquaviva.2005.167">Acquaviva et al 2005</a>], while the only pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (c.1553T&#x0003e;C) located in the middle of this segment affects a highly conserved amino acid [<a class="bk_pop" href="#mma.REF.worgan.2006.31">Worgan et al 2006</a>].</p><p>Most of the mut<sup>&#x02013;</sup> enzymatic subtype pathogenic variants reside in the cobalamin binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, which is located between amino acids 578 and 750. Some pathogenic variants in this region can display purely K<sub>m</sub> effects, as could be expected for a cofactor binding <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, while others affect the K<sub>m</sub> and V<sub>max</sub> [<a class="bk_pop" href="#mma.REF.janata.1997.1457">Janata et al 1997</a>]. This region also contains residues that can participate in interallelic complementation [<a class="bk_pop" href="#mma.REF.ledley.1997.1">Ledley &#x00026; Rosenblatt 1997</a>].</p><p>Detailed functional characterization is available for a small number of <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants shown to cause (a) reduced protein level due to misfolding, (b) increased thermolability, (c) impaired enzyme activity, and (d) reduced cofactor response in substrate turnover [<a class="bk_pop" href="#mma.REF.forny.2014.1449">Forny et al 2014</a>].</p><p><b><i>MCEE</i></b></p><p><b>Gene structure.</b>
<i>MCEE</i> comprises four exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1231/#mma.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> After the initial identification of two individuals with methylmalonic aciduria who were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the p.Arg47Ter <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#mma.REF.bikker.2006.640">Bikker et al 2006</a>, <a class="bk_pop" href="#mma.REF.dobson.2006.327">Dobson et al 2006</a>], an additional four of 229 individuals with elevated MMA of unknown etiology were reported to have a pathogenic variant in <i>MCEE</i> [<a class="bk_pop" href="#mma.REF.gradinger.2007.1045">Gradinger et al 2007</a>]. Two persons with decreased [<sup>14</sup>C]propionate incorporation were homozygous for the pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant c.139C&#x0003e;T in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2. Among 199 persons with normal [<sup>14</sup>C]propionate incorporation, one was homozygous for the novel pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant c.178A&#x0003e;C in exon 2, and two were <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the novel pathogenic missense variant c.427C&#x0003e;T in exon 3.</p><div id="mma.T.mcee_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>MCEE</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.T.mcee_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.T.mcee_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.139C&#x0003e;T</td><td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg47Ter</td><td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/188035927" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032601<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_115990.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_115990<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.178A&#x0003e;C</td><td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys60Gln</td></tr><tr><td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.427C&#x0003e;T</td><td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg143Cys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>MCEE</i> encodes the 176-amino-acid enzyme methylmalonyl-CoA epimerase, which converts D-methylmalonyl-CoA to L-methylmalonyl-CoA.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>. The pathogenic variants described to date are either <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and are predicted to decrease or eliminate function.</p><p><b><i>MMADHC</i></b></p><p><b>Gene structure.</b>
<i>MMADHC</i> (formerly <i>C2orf25</i>) comprises eight exons and spans 18 kb [<a class="bk_pop" href="#mma.REF.coelho.2008.1454">Coelho et al 2008</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1231/#mma.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants in the C-terminal region (exons 3, 4, or 5) that cause a cblD variant 2 only <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic aciduria) are listed in <a class="figpopup" href="/books/NBK1231/table/mma.T.isolated_mmaassociated_mmadhc_path/?report=objectonly" target="object" rid-figpopup="figmmaTisolatedmmaassociatedmmadhcpath" rid-ob="figobmmaTisolatedmmaassociatedmmadhcpath">Table 7</a>.</p><p>Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in the N-terminal region (exons 6 and 8) cause cblD variant 1 only <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> homocystinuria), while truncating pathogenic variants in exons 5 and 8 and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 7 cause the classic cblD phenotype (combined homocystinuria and methylmalonic aciduria) [<a class="bk_pop" href="#mma.REF.coelho.2008.1454">Coelho et al 2008</a>, <a class="bk_pop" href="#mma.REF.miousse.2009.551">Miousse et al 2009</a>].</p><div id="mma.T.isolated_mmaassociated_mmadhc_path" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Isolated MMA-Associated <i>MMADHC</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1231/table/mma.T.isolated_mmaassociated_mmadhc_path/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mma.T.isolated_mmaassociated_mmadhc_path_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.57_64delCTCTTTAG</td><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser20Ter<br />(Cys19fsTer20)</td><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/215422307" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015702<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/7661548" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056517<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.60_61insAT<br />(60insAT)</td><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu21IlefsTer2<br />(Leu20fsTer21)</td></tr><tr><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.133dupG</td><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg45GlyfsTer15</td></tr><tr><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.160C&#x0003e;T</td><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg54Ter</td></tr><tr><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.228dupG</td><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn77GlufsTer5</td></tr><tr><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.307_324dup</td><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu103_Ser108dup</td></tr><tr><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.455dupC</td><td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys153MetfsTer10<br />(Thr152fsTer162)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="mma.TF.7.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>MMADHC</i> product is predicted to have 296 amino acids with a calculated molecular mass of 32.8 kd. It shows homology to the putative ATPase component of a bacterial ABC transporter. There is an N-terminal mitochondrial leader sequence and a predicted B<sub>12</sub> binding sequence [<a class="bk_pop" href="#mma.REF.coelho.2008.1454">Coelho et al 2008</a>] and MMADHC has been localized to both the cytoplasm and mitochondria in vitro [<a class="bk_pop" href="#mma.REF.mah.2013.112">Mah et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>cblD</i>-MMA mutated alleles (c.57_64delCTCTTTAG, c.60_61insAT, c.133dupG, c.160C&#x0003e;T, and c.228dupG) were expressed in an immortalized cell line from a patient with the <i>cblD</i>-combined <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and were able to rescue MeCbl synthesis [<a class="bk_pop" href="#mma.REF.stucki.2012.1410">Stucki et al 2012</a>]. This work showed that additional reinitiation codons at Met62 and Met116 result in shorter functional <i>cblD</i> proteins that lack the putative mitochondrial leader sequence but allow for normal methylcobalamin synthesis [<a class="bk_pop" href="#mma.REF.coelho.2008.1454">Coelho et al 2008</a>, <a class="bk_pop" href="#mma.REF.stucki.2012.1410">Stucki et al 2012</a>]. Each patient with <i>cblD</i>-MMA reported to date appears to have at least one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> causing premature stop towards the N terminus of the enzyme.</p></div><div id="mma.References"><h2 id="_mma_References_">References</h2><div id="mma.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mma.REF.abramowicz.1994.418">Abramowicz MJ, Andrien M, Dupont E, Dorchy H, Parma J, Duprez L, Ledley FD, Courtens W, Vamos E. Isodisomy of chromosome 6 in a newborn with methylmalonic acidemia and agenesis of pancreatic beta cells causing diabetes mellitus. <span><span class="ref-journal">J Clin Invest. </span>1994;1994;<span class="ref-vol">94</span>:418–21.</span> [<a href="/pmc/articles/PMC296325/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC296325</span></a>] [<a href="/pubmed/7913714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7913714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.acquaviva.2001.577">Acquaviva C, Benoist JF, Callebaut I, Guffon N, Ogier de Baulny H, Touati G, Aydin A, Porquet D, Elion J. N219Y, a new frequent mutation among mut(o) forms of methylmalonic acidemia in Caucasian patients. <span><span class="ref-journal">Eur J Hum Genet. </span>2001;<span class="ref-vol">9</span>:577–82.</span> [<a href="/pubmed/11528502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11528502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.acquaviva.2005.167">Acquaviva C, Benoist JF, Pereira S, Callebaut I, Koskas T, Porquet D, Elion J. Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut(o) and mut- forms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">25</span>:167–76.</span> [<a href="/pubmed/15643616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15643616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.adjalla.1998.s248">Adjalla CE, Hosack AR, Matiaszuk NV, Rosenblatt DS. A common mutation among blacks with mut- methylmalonic aciduria. <span><span class="ref-journal">Hum Mutat. </span>1998 Suppl 1:S248–50.</span> [<a href="/pubmed/9452100" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9452100</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ah_mew.2010.e208">Ah Mew N, McCarter R, Daikhin Y, Nissim I, Yudkoff M, Tuchman M. N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia. <span><span class="ref-journal">Pediatrics. </span>2010;<span class="ref-vol">126</span>:e208–14.</span> [<a href="/pmc/articles/PMC3297024/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3297024</span></a>] [<a href="/pubmed/20566609" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20566609</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.alfares.2011.602">Alfares A, Nunez LD, Al-Thihli K, Mitchell J, Melan&#x000e7;on S, Anastasio N, Ha KC, Majewski J, Rosenblatt DS, Braverman N. Combined malonic and methylmalonic aciduria: exome sequencing reveals mutations in the ACSF3 gene in patients with a non-classic phenotype. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:602–5.</span> [<a href="/pubmed/21785126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21785126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.alowain.2004.239">Al-Owain M, Freehauf C, Bernstein L, Kappy M, Thomas J. Growth hormone deficiency associated with methylmalonic acidemia. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2004;<span class="ref-vol">17</span>:239–43.</span> [<a href="/pubmed/15055362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15055362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ampola.1975.313">Ampola MG, Mahoney MJ, Nakamura E, Tanaka K. Prenatal therapy of a patient with vitamin-B12-responsive methylmalonic acidemia. <span><span class="ref-journal">N Engl J Med. </span>1975;<span class="ref-vol">293</span>:313–7.</span> [<a href="/pubmed/239344" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 239344</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.atkuri.2009.3941">Atkuri KR, Cowan TM, Kwan T, Ng A, Herzenberg LA, Herzenberg LA, Enns GM. Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2009;<span class="ref-vol">106</span>:3941–5.</span> [<a href="/pmc/articles/PMC2656184/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2656184</span></a>] [<a href="/pubmed/19223582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19223582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.bain.1995.850">Bain MD, Nussey SS, Jones M, Chalmers RA. Use of human somatotrophin in the treatment of a patient with methylmalonic aciduria. <span><span class="ref-journal">Eur J Pediatr. </span>1995;<span class="ref-vol">154</span>:850–2.</span> [<a href="/pubmed/8529687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8529687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.baker.2015.194">Baker EH, Sloan JL, Hauser NS, Gropman AL, Adams DR, Toro C, Manoli I, Venditti CP. MRI characteristics of globus pallidus infarcts in isolated methylmalonic acidemia. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2015;<span class="ref-vol">36</span>:194–201.</span> [<a href="/pubmed/25190203" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25190203</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.baumgarter.1995.138">Baumgarter ER, Viardot C. Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>1995;<span class="ref-vol">18</span>(2):138–42.</span> [<a href="/pubmed/7564229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7564229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.baumgartner.2014.130">Baumgartner MR, H&#x000f6;rster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, Huemer M, Hochuli M, Assoun M, Ballhausen D, Burlina A, Fowler B, Gr&#x000fc;nert SC, Gr&#x000fc;newald S, Honzik T, Merinero B, P&#x000e9;rez-Cerd&#x000e1; C, Scholl-B&#x000fc;rgi S, Skovby F, Wijburg F, MacDonald A, Martinelli D, Sass JO, Valayannopoulos V, Chakrapani A. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:130.</span> [<a href="/pmc/articles/PMC4180313/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4180313</span></a>] [<a href="/pubmed/25205257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25205257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.bikker.2006.640">Bikker H, Bakker HD, Abeling NG, Poll-The BT, Kleijer WJ, Rosenblatt DS, Waterham HR, Wanders RJ, Duran M. A homozygous nonsense mutation in the methylmalonyl-CoA epimerase gene (MCEE) results in mild methylmalonic aciduria. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:640–3.</span> [<a href="/pubmed/16752391" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16752391</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.brassier.2013.106">Brassier A, Boyer O, Valayannopoulos V, Ottolenghi C, Krug P, Cosson MA, Touati G, Arnoux JB, Barbier V, Bahi-Buisson N, Desguerre I, Charbit M, Benoist JF, Dupic L, Aigrain Y, Blanc T, Salomon R, Rabier D, Guest G, de Lonlay P, Niaudet P. Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">110</span>:106–10.</span> [<a href="/pubmed/23751327" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23751327</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.brown.1984.21">Brown GK, Scholem RD, Bankier A, Danks DM. Malonyl coenzyme A decarboxylase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>1984;<span class="ref-vol">7</span>:21–6.</span> [<a href="/pubmed/6145813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6145813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.carrillocarrasco.2010.1147">Carrillo-Carrasco N, Chandler RJ, Chandrasekaran S, Venditti CP. Liver-directed recombinant adeno-associated viral gene delivery rescues a lethal mouse model of methylmalonic acidemia and provides long-term phenotypic correction. <span><span class="ref-journal">Hum Gene Ther. </span>2010;<span class="ref-vol">21</span>:1147–54.</span> [<a href="/pmc/articles/PMC2936498/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2936498</span></a>] [<a href="/pubmed/20486773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20486773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.carrozzo.2007.862">Carrozzo R, Dionisi-Vici C, Steuerwald U, Lucioli S, Deodato F, Di Giandomenico S, Bertini E, Franke B, Kluijtmans LA, Meschini MC, Rizzo C, Piemonte F, Rodenburg R, Santer R, Santorelli FM, van Rooij A, Vermunt-de Koning D, Morava E, Wevers RA. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:862–74.</span> [<a href="/pubmed/17301081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17301081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.celiker.2009.640">Celiker MY, Chawla A. Congenital B12 deficiency following maternal gastric bypass. <span><span class="ref-journal">J Perinatol. </span>2009;<span class="ref-vol">29</span>:640–2.</span> [<a href="/pubmed/19710657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19710657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chace.2001.2040">Chace DH, DiPerna JC, Kalas TA, Johnson RW, Naylor EW. Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. <span><span class="ref-journal">Clin Chem. </span>2001;<span class="ref-vol">47</span>:2040–4.</span> [<a href="/pubmed/11673377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11673377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chakrapani.2002.261">Chakrapani A, Sivakumar P, McKiernan PJ, Leonard JV. Metabolic stroke in methylmalonic acidemia five years after liver transplantation. <span><span class="ref-journal">J Pediatr. </span>2002;<span class="ref-vol">140</span>:261–3.</span> [<a href="/pubmed/11865284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11865284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chambliss.2000.497">Chambliss KL, Gray RG, Rylance G, Pollitt RJ, Gibson KM. Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>2000;<span class="ref-vol">23</span>:497–504.</span> [<a href="/pubmed/10947204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10947204</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chan.2015.635">Chan R, Mascarenhas L, Boles RG, Kerkar N, Genyk Y, Venkatramani R. Hepatoblastoma in a patient with methylmalonic aciduria. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:635–8.</span> [<a href="/pubmed/25691417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25691417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chandler.2007.64">Chandler RJ, Sloan J, Fu H, Tsai M, Stabler S, Allen R, Kaestner KH, Kazazian HH, Venditti CP. Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. <span><span class="ref-journal">BMC Med Genet. </span>2007;<span class="ref-vol">8</span>:64.</span> [<a href="/pmc/articles/PMC2140053/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2140053</span></a>] [<a href="/pubmed/17937813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17937813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chandler.2008.53">Chandler RJ, Venditti CP. Adenovirus-mediated gene delivery rescues a neonatal lethal murine model of mut(0) methylmalonic acidemia. <span><span class="ref-journal">Hum Gene Ther. </span>2008;<span class="ref-vol">19</span>:53–60.</span> [<a href="/pmc/articles/PMC2683146/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2683146</span></a>] [<a href="/pubmed/18052792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18052792</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chandler.2010.11">Chandler RJ, Venditti CP. Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy. <span><span class="ref-journal">Mol Ther. </span>2010;<span class="ref-vol">18</span>:11–6.</span> [<a href="/pmc/articles/PMC2839224/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2839224</span></a>] [<a href="/pubmed/19861951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19861951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chandler.2012.617">Chandler RJ, Venditti CP. Pre-clinical efficacy and dosing of an AAV8 vector expressing human methylmalonyl-CoA mutase in a murine model of methylmalonic acidemia (MMA). <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">107</span>:617–9.</span> [<a href="/pmc/articles/PMC3522145/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3522145</span></a>] [<a href="/pubmed/23046887" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23046887</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chandler.2009.1252">Chandler RJ, Zerfas PM, Shanske S, Sloan J, Hoffmann V, DiMauro S, Venditti CP. Mitochondrial dysfunction in mut methylmalonic acidemia. <span><span class="ref-journal">FASEB J. </span>2009;<span class="ref-vol">23</span>:1252–61.</span> [<a href="/pmc/articles/PMC2660647/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2660647</span></a>] [<a href="/pubmed/19088183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19088183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.chang.2000.295">Chang PF, Huang SF, Hwu WL, Hou JW, Ni YH, Chang MH. Metabolic disorders mimicking Reye's syndrome. <span><span class="ref-journal">J Formos Med Assoc. </span>2000;<span class="ref-vol">99</span>:295–9.</span> [<a href="/pubmed/10870312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10870312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ciani.2000.2119">Ciani F, Donati MA, Tulli G, Poggi GM, Pasquini E, Rosenblatt DS, Zammarchi E. Lethal late onset cblB methylmalonic aciduria. <span><span class="ref-journal">Crit Care Med. </span>2000;<span class="ref-vol">28</span>:2119–21.</span> [<a href="/pubmed/10890676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10890676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.clothier.2011.695">Clothier JC, Chakrapani A, Preece MA, McKiernan P, Gupta R, Macdonald A, Hulton SA. Renal transplantation in a boy with methylmalonic acidaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>2011;<span class="ref-vol">34</span>:695–700.</span> [<a href="/pubmed/21416195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21416195</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.coelho.2012.1152">Coelho D, Kim JC, Miousse IR, Fung S, du Moulin M, Buers I, Suormala T, Burda P, Frapolli M, Stucki M, N&#x000fc;rnberg P, Thiele H, Robenek H, H&#x000f6;hne W, Longo N, Pasquali M, Mengel E, Watkins D, Shoubridge EA, Majewski J, Rosenblatt DS, Fowler B, Rutsch F, Baumgartner MR. Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1152–5.</span> [<a href="/pubmed/22922874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22922874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.coelho.2008.1454">Coelho D, Suormala T, Stucki M, Lerner-Ellis JP, Rosenblatt DS, Newbold RF, Baumgartner MR, Fowler B. Gene identification for the cblD defect of vitamin B12 metabolism. <span><span class="ref-journal">N Engl J Med. </span>2008;<span class="ref-vol">358</span>:1454–64.</span> [<a href="/pubmed/18385497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18385497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.coman.2006.270">Coman D, Huang J, McTaggart S, Sakamoto O, Ohura T, McGill J, Burke J. Renal transplantation in a 14-year-old girl with vitamin B12-responsive cblA-type methylmalonic acidaemia. <span><span class="ref-journal">Pediatr Nephrol. </span>2006;<span class="ref-vol">21</span>:270–3.</span> [<a href="/pubmed/16247646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16247646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.cosson.2008.107">Cosson MA, Touati G, Lacaille F, Valayannnopoulos V, Guyot C, Guest G, Verkarre V, Chr&#x000e9;tien D, Rabier D, Munnich A, Benoist JF, de Keyzer Y, Niaudet P, de Lonlay P. Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">95</span>:107–9.</span> [<a href="/pubmed/18676166" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18676166</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.coulombe.1981.26">Coulombe JT, Shih VE, Levy HL. Massachusetts Metabolic Disorders Screening Program. II. Methylmalonic aciduria. <span><span class="ref-journal">Pediatrics. </span>1981;<span class="ref-vol">67</span>:26–31.</span> [<a href="/pubmed/7243433" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7243433</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.crane.1992.385">Crane AM, Jansen R, Andrews ER, Ledley FD. Cloning and expression of a mutant methylmalonyl coenzyme A mutase with altered cobalamin affinity that causes mut- methylmalonic aciduria. <span><span class="ref-journal">J Clin Invest. </span>1992;<span class="ref-vol">89</span>:385–91.</span> [<a href="/pmc/articles/PMC442864/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC442864</span></a>] [<a href="/pubmed/1346616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1346616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.crane.1994.42">Crane AM, Ledley FD. Clustering of mutations in methylmalonyl CoA mutase associated with mut- methylmalonic acidemia. <span><span class="ref-journal">Am J Hum Genet. </span>1994;<span class="ref-vol">55</span>:42–50.</span> [<a href="/pmc/articles/PMC1918235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1918235</span></a>] [<a href="/pubmed/7912889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7912889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.dangio.1991.259">D'Angio CT, Dillon MJ, Leonard JV. Renal tubular dysfunction in methylmalonic acidaemia. <span><span class="ref-journal">Eur J Pediatr. </span>1991;<span class="ref-vol">150</span>:259–63.</span> [<a href="/pubmed/2029917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2029917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.de_baulny.2005.415">de Baulny HO, Benoist JF, Rigal O, Touati G, Rabier D, Saudubray JM. Methylmalonic and propionic acidaemias: management and outcome. <span><span class="ref-journal">J Inherit Metab Dis. </span>2005;<span class="ref-vol">28</span>:415–23.</span> [<a href="/pubmed/15868474" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15868474</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.de_keyzer.2009.91">de Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F, Hubert L, Chr&#x000e9;tien D, Chadefeaux-Vekemans B, Niaudet P, Touati G, Munnich A, de Lonlay P. Multiple OXPHOS deficiency in the liver, kidney, heart and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. <span><span class="ref-journal">Pediatr Res. </span>2009;<span class="ref-vol">66</span>:91–5.</span> [<a href="/pubmed/19342984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19342984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.de_raeve.1994.416">De Raeve L, De Meirleir L, Ramet J, Vandenplas Y, Gerlo E. Acrodermatitis enteropathica-like cutaneous lesions in organic aciduria. <span><span class="ref-journal">J Pediatr. </span>1994;<span class="ref-vol">124</span>:416–20.</span> [<a href="/pubmed/8120711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8120711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.deodato.2002.133">Deodato F, Rizzo C, Boenzi S, Baiocco F, Sabetta G, Dionisi-Vici C. Successful pregnancy in a woman with mut- methylmalonic acidaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>2002;<span class="ref-vol">25</span>:133–4.</span> [<a href="/pubmed/12118529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12118529</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.dietzen.2009.1615">Dietzen DJ, Rinaldo P, Whitley RJ, Rhead WJ, Hannon WH, Garg UC, Lo SF, Bennett MJ. National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary. <span><span class="ref-journal">Clin Chem. </span>2009;<span class="ref-vol">55</span>:1615–26.</span> [<a href="/pubmed/19574465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19574465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.dionisivici.2006.383">Dionisi-Vici C, Deodato F, R&#x000f6;schinger W, Rhead W, Wilcken B. 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. <span><span class="ref-journal">J Inherit Metab Dis. </span>2006;<span class="ref-vol">29</span>:383–9.</span> [<a href="/pubmed/16763906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16763906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.dobson.2006.327">Dobson CM, Gradinger A, Longo N, Wu X, Leclerc D, Lerner-Ellis J, Lemieux M, Belair C, Watkins D, Rosenblatt DS, Gravel RA. Homozygous nonsense mutation in the MCEE gene and siRNA suppression of methylmalonyl-CoA epimerase expression: a novel cause of mild methylmalonic aciduria. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">88</span>:327–33.</span> [<a href="/pubmed/16697227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16697227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.dobson.2002a.3361">Dobson CM, Wai T, Leclerc D, Kadir H, Narang M, Lerner-Ellis JP, Hudson TJ, Rosenblatt DS, Gravel RA. Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria. <span><span class="ref-journal">Hum Mol Genet. </span>2002a;<span class="ref-vol">11</span>:3361–9.</span> [<a href="/pubmed/12471062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12471062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.dobson.2002b.15554">Dobson CM, Wai T, Leclerc D, Wilson A, Wu X, Dore C, Hudson T, Rosenblatt DS, Gravel RA. Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2002b;<span class="ref-vol">99</span>:15554–9.</span> [<a href="/pmc/articles/PMC137755/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC137755</span></a>] [<a href="/pubmed/12438653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12438653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.dudley.1998.564">Dudley J, Allen J, Tizard J, McGraw M. Benign methylmalonic acidemia in a sibship with distal renal tubular acidosis. <span><span class="ref-journal">Pediatr Nephrol. </span>1998;<span class="ref-vol">12</span>:564–6.</span> [<a href="/pubmed/9761355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9761355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.elpeleg.2005.1081">Elpeleg O, Miller C, Hershkovitz E, Bitner-Glindzicz M, Bondi-Rubinstein G, Rahman S, Pagnamenta A, Eshhar S, Saada A. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:1081–6.</span> [<a href="/pmc/articles/PMC1196446/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196446</span></a>] [<a href="/pubmed/15877282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15877282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.fenton.2001">Fenton WA, Gravel RA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) <em>The Metabolic and Molecular Bases of Inherited Disease</em>. New York, NY: McGraw-Hill. 2001:2165-92.</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.forny.2014.1449">Forny P, Froese DS, Suormala T, Yue WW, Baumgartner MR. Functional characterization and categorization of missense mutations that cause methylmalonyl-CoA mutase (MUT) deficiency. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:1449–58.</span> [<a href="/pmc/articles/PMC4441004/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4441004</span></a>] [<a href="/pubmed/25125334" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25125334</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.fowler.2008.350">Fowler B, Leonard JV, Baumgartner MR. Causes and diagnostic approach to methylmalonic acidurias. <span><span class="ref-journal">J Inherit Metab Dis. </span>2008;<span class="ref-vol">31</span>:350–60.</span> [<a href="/pubmed/18563633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18563633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.froese.2013.1182">Froese DS, Forouhar F, Tran TH, Vollmar M, Kim YS, Lew S, Neely H, Seetharaman J, Shen Y, Xiao R, Acton TB, Everett JK, Cannone G, Puranik S, Savitsky P, Krojer T, Pilka ES, Kiyani W, Lee WH, Marsden BD, von Delft F, Allerston CK, Spagnolo L, Gileadi O, Montelione GT, Oppermann U, Yue WW, Tong L. Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutations. <span><span class="ref-journal">Structure. </span>2013;<span class="ref-vol">21</span>:1182–92.</span> [<a href="/pmc/articles/PMC3701320/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3701320</span></a>] [<a href="/pubmed/23791943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23791943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.fuchshuber.2000.179">Fuchshuber A, Mucha B, Baumgartner ER, Vollmer M, Hildebrandt F. mut0 methylmalonic acidemia: eleven novel mutations of the methylmalonyl CoA mutase including a deletion-insertion mutation. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">16</span>:179.</span> [<a href="/pubmed/10923046" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10923046</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.giorgio.1976.310">Giorgio AJ, Trowbridge M, Boone AW, Patten RS. Methylmalonic aciduria without vitamin B12 deficiency in an adult sibship. <span><span class="ref-journal">N Engl J Med. </span>1976;<span class="ref-vol">295</span>:310–3.</span> [<a href="/pubmed/6909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.gradinger.2007.1045">Gradinger AB, B&#x000e9;lair C, Worgan LC, Li CD, Lavall&#x000e9;e J, Roquis D, Watkins D, Rosenblatt DS. Atypical methylmalonic aciduria: frequency of mutations in the methylmalonyl CoA epimerase gene (MCEE). <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:1045.</span> [<a href="/pubmed/17823972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17823972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.grange.1994.311">Grange DK, Finlay JL. Nutritional vitamin B12 deficiency in a breastfed infant following maternal gastric bypass. <span><span class="ref-journal">Pediatr Hematol Oncol. </span>1994;<span class="ref-vol">11</span>:311–8.</span> [<a href="/pubmed/8060815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8060815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.gu.2014.564">Gu W, Koh W, Blumenfeld YJ, El-Sayed YY, Hudgins L, Hintz SR, Quake SR. Noninvasive prenatal diagnosis in a fetus at risk for methylmalonic acidemia. <span><span class="ref-journal">Genet Med. </span>2014;<span class="ref-vol">16</span>:564–7.</span> [<a href="/pmc/articles/PMC4079742/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4079742</span></a>] [<a href="/pubmed/24406457" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24406457</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.guerramoreno.2003.17">Guerra-Moreno J, Barrios N, Santiago-Borrero PJ. Severe neutropenia in an infant with methylmalonic acidemia. <span><span class="ref-journal">Bol Asoc Med P R. </span>2003;<span class="ref-vol">95</span>:17–20.</span> [<a href="/pubmed/12898746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12898746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.harting.2008.368">Harting I, Seitz A, Geb S, Zwickler T, Porto L, Lindner M, K&#x000f6;lker S, H&#x000f6;rster F. Looking beyond the basal ganglia: the spectrum of MRI changes in methylmalonic acidaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>2008;<span class="ref-vol">31</span>:368–78.</span> [<a href="/pubmed/18470632" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18470632</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.hauser.2011.47">Hauser NS, Manoli I, Graf JC, Sloan J, Venditti CP. Variable dietary management of methylmalonic acidemia: metabolic and energetic correlations. <span><span class="ref-journal">Am J Clin Nutr. </span>2011;<span class="ref-vol">93</span>:47–56.</span> [<a href="/pmc/articles/PMC3001598/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3001598</span></a>] [<a href="/pubmed/21048060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21048060</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.heidenreich.1988.1022">Heidenreich R, Natowicz M, Hainline BE, Berman P, Kelley RI, Hillman RE, Berry GT. Acute extrapyramidal syndrome in methylmalonic acidemia: "metabolic stroke" involving the globus pallidus. <span><span class="ref-journal">J Pediatr. </span>1988;<span class="ref-vol">113</span>:1022–7.</span> [<a href="/pubmed/3193307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3193307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.h_rster.2007.225">H&#x000f6;rster F, Baumgartner MR, Viardot C, Suormala T, Burgard P, Fowler B, Hoffmann GF, Garbade SF, K&#x000f6;lker S, Baumgartner ER. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). <span><span class="ref-journal">Pediatr Res. </span>2007;<span class="ref-vol">62</span>:225–30.</span> [<a href="/pubmed/17597648" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17597648</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.hsui.2003.171">Hsui JY, Chien YH, Chu SY, Lu FL, Chen HL, Ho MJ, Lee PH, Hwu WL. Living-related liver transplantation for methylmalonic acidemia: report of one case. <span><span class="ref-journal">Acta Paediatr Taiwan. </span>2003;<span class="ref-vol">44</span>:171–3.</span> [<a href="/pubmed/14521026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14521026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.hubbard.2007.31308">Hubbard PA, Padovani D, Labunska T, Mahlstedt SA, Banerjee R, Drennan CL. Crystal structure and mutagenesis of the metallochaperone MeaB: insight into the causes of methylmalonic aciduria. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>:31308–16.</span> [<a href="/pubmed/17728257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17728257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.iles.1986.173">Iles RA, Chalmers RA, Hind AJ. Methylmalonic aciduria and propionic acidaemia studied by proton nuclear magnetic resonance spectroscopy. <span><span class="ref-journal">Clin Chim Acta. </span>1986;<span class="ref-vol">161</span>:173–89.</span> [<a href="/pubmed/3802528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3802528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.inoue.1981.95">Inoue S, Krieger I, Sarnaik A, Ravindranath Y, Fracassa M, Ottenbreit MJ. Inhibition of bone marrow stem cell growth in vitro by methylmalonic acid: a mechanism for pancytopenia in a patient with methylmalonic acidemia. <span><span class="ref-journal">Pediatr Res. </span>1981;<span class="ref-vol">15</span>:95–8.</span> [<a href="/pubmed/7254944" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7254944</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.janata.1997.1457">Janata J, Kogekar N, Fenton WA. Expression and kinetic characterization of methylmalonyl-CoA mutase from patients with the mut- phenotype: evidence for naturally occurring interallelic complementation. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:1457–64.</span> [<a href="/pubmed/9285782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9285782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.jung.2005.367">Jung JW, Hwang IT, Park JE, Lee EH, Ryu KH, Kim SH, Hwang JS. Mutation analysis of the MCM gene in Korean patients with MMA. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">84</span>:367–70.</span> [<a href="/pubmed/15781199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15781199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.kahler.1994.239">Kahler SG, Sherwood WG, Woolf D, Lawless ST, Zaritsky A, Bonham J, Taylor CJ, Clarke JT, Durie P, Leonard JV. Pancreatitis in patients with organic acidemias. <span><span class="ref-journal">J Pediatr. </span>1994;<span class="ref-vol">124</span>:239–43.</span> [<a href="/pubmed/8301430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8301430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.kaplan.2006.322">Kaplan P, Ficicioglu C, Mazur AT, Palmieri MJ, Berry GT. Liver transplantation is not curative for methylmalonic acidopathy caused by methylmalonyl-CoA mutase deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">88</span>:322–6.</span> [<a href="/pubmed/16750411" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16750411</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.karth.2012.398">Karth P, Singh R, Kim J, Costakos D. Bilateral central retinal artery occlusions in an infant with hyperhomocysteinemia. <span><span class="ref-journal">J AAPOS. </span>2012;<span class="ref-vol">16</span>:398–400.</span> [<a href="/pubmed/22819238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22819238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.kasahara.2006.943">Kasahara M, Horikawa R, Tagawa M, Uemoto S, Yokoyama S, Shibata Y, Kawano T, Kuroda T, Honna T, Tanaka K, Saeki M. Current role of liver transplantation for methylmalonic acidemia: a review of the literature. <span><span class="ref-journal">Pediatr Transplant. </span>2006;<span class="ref-vol">10</span>:943–7.</span> [<a href="/pubmed/17096763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17096763</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.kayler.2002.295">Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, Turcotte JG, Campbell DA Jr, Holmes R, Magee JC. Long-term survival after liver transplantation in children with metabolic disorders. <span><span class="ref-journal">Pediatr Transplant. </span>2002;<span class="ref-vol">6</span>:295–300.</span> [<a href="/pubmed/12234269" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12234269</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.k_lker.2015a.1041">K&#x000f6;lker S, Cazorla AG, Valayannopoulos V, Lund AM, Burlina AB, Sykut-Cegielska J, Wijburg FA, Teles EL, Zeman J, Dionisi-Vici C, Bari&#x00107; I, Karall D, Augoustides-Savvopoulou P, Aksglaede L, Arnoux JB, Avram P, Baumgartner MR, Blasco-Alonso J, Chabrol B, Chakrapani A, Chapman K. I Saladelafont EC, Couce ML, de Meirleir L, Dobbelaere D, Dvorakova V, Furlan F, Gleich F, Gradowska W, Gr&#x000fc;newald S, Jalan A, H&#x000e4;berle J, Haege G, Lachmann R, Laemmle A, Langereis E, de Lonlay P, Martinelli D, Matsumoto S, M&#x000fc;hlhausen C, de Baulny HO, Ortez C, Pe&#x000f1;a-Quintana L, Ramad&#x0017e;a DP, Rodrigues E, Scholl-B&#x000fc;rgi S, Sokal E, Staufner C, Summar ML, Thompson N, Vara R, Pinera IV, Walter JH, Williams M, Burgard P. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015a;<span class="ref-vol">38</span>:1041–57.</span> [<a href="/pubmed/25875215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25875215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.k_lker.2015b.1059">K&#x000f6;lker S, Valayannopoulos V, Burlina AB, Sykut-Cegielska J, Wijburg FA, Teles EL, Zeman J, Dionisi-Vici C, Bari&#x00107; I, Karall D, Arnoux JB, Avram P, Baumgartner MR, Blasco-Alonso J, Boy SP, Rasmussen MB, Burgard P, Chabrol B, Chakrapani A, Chapman K, Cort&#x000e8;s I, Saladelafont E, Couce ML, de Meirleir L, Dobbelaere D, Furlan F, Gleich F, Gonz&#x000e1;lez MJ, Gradowska W, Gr&#x000fc;newald S, Honzik T, H&#x000f6;rster F, Ioannou H, Jalan A, H&#x000e4;berle J, Haege G, Langereis E, de Lonlay P, Martinelli D, Matsumoto S, M&#x000fc;hlhausen C, Murphy E, de Baulny HO, Ortez C, Pedr&#x000f3;n CC, Pintos-Morell G, Pena-Quintana L, Ramad&#x0017e;a DP, Rodrigues E, Scholl-B&#x000fc;rgi S, Sokal E, Summar ML, Thompson N, Vara R, Pinera IV, Walter JH, Williams M, Lund AM. Garcia Cazorla A. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015b Nov;<span class="ref-vol">38</span>(6):1059–74.</span> [<a href="/pubmed/25875216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25875216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.korf.1986.364">Korf B, Wallman JK, Levy HL. Bilateral lucency of the globus pallidus complicating methylmalonic acidemia. <span><span class="ref-journal">Ann Neurol. </span>1986;<span class="ref-vol">20</span>:364–6.</span> [<a href="/pubmed/3767321" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3767321</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.korotkova.2004.13652">Korotkova N, Lidstrom ME. MeaB is a component of the methylmalonyl-CoA mutase complex required for protection of the enzyme from inactivation. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:13652–8.</span> [<a href="/pubmed/14734568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14734568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.kruszka.2013.990">Kruszka PS, Manoli I, Sloan JL, Kopp JB, Venditti CP. Renal growth in isolated methylmalonic acidemia. <span><span class="ref-journal">Genet Med. </span>2013;<span class="ref-vol">15</span>:990–6.</span> [<a href="/pmc/articles/PMC4149057/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4149057</span></a>] [<a href="/pubmed/23639900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23639900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ktena.2015a.2075">Ktena YP, Paul SM, Hauser NS, Sloan JL, Gropman A, Manoli I, Venditti CP. Delineating the spectrum of impairments, disabilities, and rehabilitation needs in methylmalonic acidemia (MMA). <span><span class="ref-journal">Am J Med Genet A. </span>2015a Sep;<span class="ref-vol">167A</span>(9):2075–84.</span> [<a href="/pubmed/25959030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25959030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ktena.2015b.847">Ktena YP, Ramstad T, Baker EH, Sloan JL, Mannes AJ, Manoli I, Venditti CP. Propofol administration in patients with methylmalonic acidemia and intracellular cobalamin metabolism disorders: a review of theoretical concerns and clinical experiences in 28 patients. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015b;<span class="ref-vol">38</span>:847–53.</span> [<a href="/pmc/articles/PMC5577977/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5577977</span></a>] [<a href="/pubmed/25985870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25985870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.la_marca.2008.s395">la Marca G, Malvagia S, Casetta B, Pasquini E, Donati MA, Zammarchi E. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests. <span><span class="ref-journal">J Inherit Metab Dis. </span>2008;<span class="ref-vol">31</span> Suppl 2:S395–404.</span> [<a href="/pubmed/18956250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18956250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.leal.2003.9227">Leal NA, Park SD, Kima PE, Bobik TA. Identification of the human and bovine ATP:Cob(I)alamin adenosyltransferase cDNAs based on complementation of a bacterial mutant. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:9227–34.</span> [<a href="/pubmed/12514191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12514191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ledley.1984.1015">Ledley FD, Levy HL, Shih VE, Benjamin R, Mahoney MJ. Benign methylmalonic aciduria. <span><span class="ref-journal">N Engl J Med. </span>1984;<span class="ref-vol">311</span>:1015–8.</span> [<a href="/pubmed/6148691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6148691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ledley.1997.1">Ledley FD, Rosenblatt DS. Mutations in mut methylmalonic acidemia: clinical and enzymatic correlations. <span><span class="ref-journal">Hum Mutat. </span>1997;<span class="ref-vol">9</span>:1–6.</span> [<a href="/pubmed/8990001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8990001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.leipe.2002.41">Leipe DD, Wolf YI, Koonin EV, Aravind L. Classification and evolution of P-loop GTPases and related ATPases. <span><span class="ref-journal">J Mol Biol. </span>2002;<span class="ref-vol">317</span>:41–72.</span> [<a href="/pubmed/11916378" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11916378</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.lempp.2007.284">Lempp TJ, Suormala T, Siegenthaler R, Baumgartner ER, Fowler B, Steinmann B, Baumgartner MR. Mutation and biochemical analysis of 19 probands with mut0 and 13 with mut- methylmalonic aciduria: identification of seven novel mutations. <span><span class="ref-journal">Mol Genet Metab. </span>2007;<span class="ref-vol">90</span>:284–90.</span> [<a href="/pubmed/17113806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17113806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.leonard.1997.s67">Leonard JV. Stable isotope studies in propionic and methylmalonic acidaemia. <span><span class="ref-journal">Eur J Pediatr. </span>1997;<span class="ref-vol">156</span>:S67–9.</span> [<a href="/pubmed/9266219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9266219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.leonard.2003.s21">Leonard JV, Vijayaraghavan S, Walter JH. The impact of screening for propionic and methylmalonic acidaemia. <span><span class="ref-journal">Eur J Pediatr. </span>2003;<span class="ref-vol">162</span>:S21–4.</span> [<a href="/pubmed/14586648" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14586648</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.lernerellis.2004.509">Lerner-Ellis JP, Dobson CM, Wai T, Watkins D, Tirone JC, Leclerc D, Dore C, Lepage P, Gravel RA, Rosenblatt DS. Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolism. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">24</span>:509–16.</span> [<a href="/pubmed/15523652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15523652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.lernerellis.2006.219">Lerner-Ellis JP, Gradinger AB, Watkins D, Tirone JC, Villeneuve A, Dobson CM, Montpetit A, Lepage P, Gravel RA, Rosenblatt DS. Mutation and biochemical analysis of patients belonging to the cblB complementation class of vitamin B12-dependent methylmalonic aciduria. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">87</span>:219–25.</span> [<a href="/pubmed/16410054" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16410054</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.lindner.2008.379">Lindner M, Ho S, K&#x000f6;lker S, Abdoh G, Hoffmann GF, Burgard P. Newborn screening for methylmalonic acidurias--optimization by statistical parameter combination. <span><span class="ref-journal">J Inherit Metab Dis. </span>2008;<span class="ref-vol">31</span>:379–85.</span> [<a href="/pubmed/18563635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18563635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.lubrano.2007.1209">Lubrano R, Elli M, Rossi M, Travasso E, Raggi C, Barsotti P, Carducci C, Berloco P. Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature. <span><span class="ref-journal">Pediatr Nephrol. </span>2007;<span class="ref-vol">22</span>:1209–14.</span> [<a href="/pubmed/17401587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17401587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.lubrano.2013.2067">Lubrano R, Perez B, Elli M. Methylmalonic acidemia and kidney transplantation. <span><span class="ref-journal">Pediatr Nephrol. </span>2013;<span class="ref-vol">28</span>:2067–8.</span> [<a href="/pubmed/23793882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23793882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.lubrano.2001.848">Lubrano R, Scoppi P, Barsotti P, Travasso E, Scateni S, Cristaldi S, Castello MA. Kidney transplantation in a girl with methylmalonic acidemia and end stage renal failure. <span><span class="ref-journal">Pediatr Nephrol. </span>2001;<span class="ref-vol">16</span>:848–51.</span> [<a href="/pubmed/11685586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11685586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.macfarland.2015.1840">MacFarland S, Hartung H. Pancytopenia in a patient with methylmalonic acidemia. <span><span class="ref-journal">Blood. </span>2015;<span class="ref-vol">125</span>:1840.</span> [<a href="/pubmed/25927084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25927084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.mah.2013.112">Mah W, Deme JC, Watkins D, Fung S, Janer A, Shoubridge EA, Rosenblatt DS, Coulton JW. Subcellular location of MMACHC and MMADHC, two human proteins central to intracellular vitamin B(12) metabolism. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">108</span>:112–8.</span> [<a href="/pubmed/23270877" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23270877</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.manoli.2016a.396">Manoli I, Myles JG, Sloan JL, Carrillo-Carrasco N, Morava E, Strauss KA, Morton H, Venditti CP. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency. <span><span class="ref-journal">Genet Med. </span>2016a Apr;<span class="ref-vol">18</span>(4):396–404.</span> [<a href="/pmc/articles/PMC4752912/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4752912</span></a>] [<a href="/pubmed/26270766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26270766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.manoli.2016b.386">Manoli I, Myles JG, Sloan JL, Shchelochkov OA, Venditti CP. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias. <span><span class="ref-journal">Genet Med. </span>2016b Apr;<span class="ref-vol">18</span>(4):386–95.</span> [<a href="/pmc/articles/PMC4752925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4752925</span></a>] [<a href="/pubmed/26270765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26270765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.manoli.2013.13552">Manoli I, Sysol JR, Li L, Houillier P, Garone C, Wang C, Zerfas PM, Cusmano-Ozog K, Young S, Trivedi NS, Cheng J, Sloan JL, Chandler RJ, Abu-Asab M, Tsokos M, Elkahloun AG, Rosen S, Enns GM, Berry GT, Hoffmann V, DiMauro S, Schnermann J, Venditti CP. Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2013;<span class="ref-vol">110</span>:13552–7.</span> [<a href="/pmc/articles/PMC3746875/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3746875</span></a>] [<a href="/pubmed/23898205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23898205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.marble.2008.731">Marble M, Copeland S, Khanfar N, Rosenblatt DS. Neonatal vitamin B12 deficiency secondary to maternal subclinical pernicious anemia: identification by expanded newborn screening. <span><span class="ref-journal">J Pediatr. </span>2008;<span class="ref-vol">152</span>:731–3.</span> [<a href="/pubmed/18410783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18410783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.marcadier.2013.98">Marcadier JL, Smith AM, Pohl D, Schwartzentruber J, Al-Dirbashi OY., FORGE Canada Consortium.  Majewski J, Ferdinandusse S, Wanders RJ, Bulman DE, Boycott KM, Chakraborty P, Geraghty MT. Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:98.</span> [<a href="/pmc/articles/PMC3710243/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3710243</span></a>] [<a href="/pubmed/23835272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23835272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.martens.2002.219">Martens DH, Bakker JA, van der Meer SB, Spaapen LJ. Unexplained familial benign methylmalonic aciduria. <span><span class="ref-journal">Eur J Pediatr. </span>2002;<span class="ref-vol">161</span>:219–20.</span> [<a href="/pubmed/12014390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12014390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.martinez_alvarez.2016.98">Martinez Alvarez L, Jameson E, Parry NR, Lloyd C, Ashworth JL. Optic neuropathy in methylmalonic acidemia and propionic acidemia. <span><span class="ref-journal">Br J Ophthalmol. </span>2016;<span class="ref-vol">100</span>:98–104.</span> [<a href="/pubmed/26209586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26209586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.mart_nez.2005.317">Mart&#x000ed;nez MA, Rinc&#x000f3;n A, Desviat LR, Merinero B, Ugarte M, P&#x000e9;rez B. Genetic analysis of three genes causing isolated methylmalonic acidemia: identification of 21 novel allelic variants. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">84</span>:317–25.</span> [<a href="/pubmed/15781192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15781192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.matern.2007.585">Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P. Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007). <span><span class="ref-journal">J Inherit Metab Dis. </span>2007;<span class="ref-vol">30</span>:585–92.</span> [<a href="/pubmed/17643193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17643193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.matsui.1983.857">Matsui SM, Mahoney MJ, Rosenberg LE. The natural history of the inherited methylmalonic acidemias. <span><span class="ref-journal">N Engl J Med. </span>1983;<span class="ref-vol">308</span>:857–61.</span> [<a href="/pubmed/6132336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6132336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.mc_guire.2009.173">Mc Guire PJ, Parikh A, Diaz GA. Profiling of oxidative stress in patients with inborn errors of metabolism. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">98</span>:173–80.</span> [<a href="/pmc/articles/PMC2915835/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2915835</span></a>] [<a href="/pubmed/19604711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19604711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.mcguire.2011.e142">McGuire MM, Jones BA, Hull MA, Misra MV, Smithers CJ, Feins NR, Jenkins RL, Lillehei CW, Harmon WE, Jonas MM, Kim HB. Combined en bloc liver-double kidney transplantation in an infant with IVC thrombosis. <span><span class="ref-journal">Pediatr Transplant. </span>2011;<span class="ref-vol">15</span>:E142–4.</span> [<a href="/pubmed/20412506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20412506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.merinero.2008.55">Merinero B, P&#x000e9;rez B, P&#x000e9;rez-Cerd&#x000e1; C, Rinc&#x000f3;n A, Desviat LR, Mart&#x000ed;nez MA, Sala PR, Garc&#x000ed;a MJ, Aldamiz-Echevarr&#x000ed;a L, Campos J, Cornejo V, Del Toro M, Mahfoud A, Mart&#x000ed;nez-Pardo M, Parini R, Pedr&#x000f3;n C, Pe&#x000f1;a-Quintana L, P&#x000e9;rez M, Pourfarzam M, Ugarte M. Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation group. <span><span class="ref-journal">J Inherit Metab Dis. </span>2008;<span class="ref-vol">31</span>:55–66.</span> [<a href="/pubmed/17957493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17957493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.miousse.2009.551">Miousse IR, Watkins D, Coelho D, Rupar T, Crombez EA, Vilain E, Bernstein JA, Cowan T, Lee-Messer C, Enns GM, Fowler B, Rosenblatt DS. Clinical and molecular heterogeneity in patients with the cblD inborn error of metabolism. <span><span class="ref-journal">J Pediatr. </span>2009;<span class="ref-vol">154</span>:551–6.</span> [<a href="/pubmed/19058814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19058814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.morava.2009.438">Morava E, Steuerwald U, Carrozzo R, Kluijtmans LA, Joensen F, Santer R, Dionisi-Vici C, Wevers RA. Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. <span><span class="ref-journal">Mitochondrion. </span>2009;<span class="ref-vol">9</span>:438–42.</span> [<a href="/pubmed/19666145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19666145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.morel.2005.160">Morel CF, Watkins D, Scott P, Rinaldo P, Rosenblatt DS. Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12 metabolism and transport. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">86</span>:160–71.</span> [<a href="/pubmed/16150626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16150626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.morioka.2007.2782">Morioka D, Kasahara M, Horikawa R, Yokoyama S, Fukuda A, Nakagawa A. Efficacy of living donor liver transplantation for patients with methylmalonic acidemia. <span><span class="ref-journal">Am J Transplant. </span>2007;<span class="ref-vol">7</span>:2782–7.</span> [<a href="/pubmed/17908273" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17908273</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.nagarajan.2005.517">Nagarajan S, Enns GM, Millan MT, Winter S, Sarwal MM. Management of methylmalonic acidaemia by combined liver-kidney transplantation. <span><span class="ref-journal">J Inherit Metab Dis. </span>2005;<span class="ref-vol">28</span>:517–24.</span> [<a href="/pubmed/15902554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15902554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.nicolaides.1998.508">Nicolaides P, Leonard J, Surtees R. Neurological outcome of methylmalonic acidaemia. <span><span class="ref-journal">Arch Dis Child. </span>1998;<span class="ref-vol">78</span>:508–12.</span> [<a href="/pmc/articles/PMC1717592/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1717592</span></a>] [<a href="/pubmed/9713004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9713004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.niemi.2015.1455">Niemi AK, Kim IK, Krueger CE, Cowan TM, Baugh N, Farrell R, Bonham CA, Concepcion W, Esquivel CO, Enns GM. Treatment of methylmalonic acidemia by liver or combined liver-kidney transplantation. <span><span class="ref-journal">J Pediatr. </span>2015 Jun;<span class="ref-vol">166</span>(6):1455–61.e1.</span> [<a href="/pubmed/25771389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25771389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.nyhan.1973.539">Nyhan WL, Fawcett N, Ando T, Rennert OM, Julius RL. Response to dietary therapy in B 12 unresponsive methylmalonic acidemia. <span><span class="ref-journal">Pediatrics. </span>1973;<span class="ref-vol">51</span>:539–48.</span> [<a href="/pubmed/4707869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4707869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.nyhan.2002.377">Nyhan WL, Gargus JJ, Boyle K, Selby R, Koch R. Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver. <span><span class="ref-journal">Eur J Pediatr. </span>2002;<span class="ref-vol">161</span>:377–9.</span> [<a href="/pubmed/12111189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12111189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.oberholzer.1967.492">Oberholzer VG, Levin B, Burgess EA, Young WF. Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. <span><span class="ref-journal">Arch Dis Child. </span>1967;<span class="ref-vol">42</span>:492–504.</span> [<a href="/pmc/articles/PMC2019805/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2019805</span></a>] [<a href="/pubmed/6061291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6061291</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ogasawara.1994.867">Ogasawara M, Matsubara Y, Mikami H, Narisawa K. Identification of two novel mutations in the methylmalonyl-CoA mutase gene with decreased levels of mutant mRNA in methylmalonic acidemia. <span><span class="ref-journal">Hum Mol Genet. </span>1994;<span class="ref-vol">3</span>:867–72.</span> [<a href="/pubmed/7951229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7951229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.oshea.2012.e1541">O'Shea CJ, Sloan JL, Wiggs EA, Pao M, Gropman A, Baker EH, Manoli I, Venditti CP, Snow J. Neurocognitive phenotype of isolated methylmalonic acidemia. <span><span class="ref-journal">Pediatrics. </span>2012;<span class="ref-vol">129</span>:e1541–51.</span> [<a href="/pmc/articles/PMC3362903/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3362903</span></a>] [<a href="/pubmed/22614770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22614770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ostergaard.2007.853">Ostergaard E, Hansen FJ, Sorensen N, Duno M, Vissing J, Larsen PL, Faeroe O, Thorgrimsson S, Wibrand F, Christensen E, Schwartz M. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:853–61.</span> [<a href="/pubmed/17287286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17287286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.pangilinan.2010.677">Pangilinan F, Mitchell A, VanderMeer J, Molloy AM, Troendle J, Conley M, Kirke PN, Sutton M, Sequeira JM, Quadros EV, Scott JM, Mills JL, Brody LC. Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:677–85.</span> [<a href="/pmc/articles/PMC4112773/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4112773</span></a>] [<a href="/pubmed/20577008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20577008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.pela.2006.63">Pela I, Gasperini S, Pasquini E, Donati MA. Hyperkalemia after acute metabolic decompensation in two children with vitamin B12-unresponsive methylmalonic acidemia and normal renal function. <span><span class="ref-journal">Clin Nephrol. </span>2006;<span class="ref-vol">66</span>:63–6.</span> [<a href="/pubmed/16878438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16878438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.pinarsueiro.2010.s199">Pinar-Sueiro S, Mart&#x000ed;nez-Fern&#x000e1;ndez R, Lage-Medina S, Aldamiz-Echevarria L, Vecino E. Optic neuropathy in methylmalonic acidemia: the role of neuroprotection. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span> Suppl 3:S199–203.</span> [<a href="/pubmed/20449661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20449661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.quadros.2010.3033">Quadros EV, Nakayama Y, Sequeira JM. Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320. <span><span class="ref-journal">Mol Cancer Ther. </span>2010;<span class="ref-vol">9</span>:3033–40.</span> [<a href="/pmc/articles/PMC2978776/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2978776</span></a>] [<a href="/pubmed/20858723" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20858723</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.radmanesh.2008.1054">Radmanesh A, Zaman T, Ghanaati H, Molaei S, Robertson RL, Zamani AA. Methylmalonic acidemia: brain imaging findings in 52 children and a review of the literature. <span><span class="ref-journal">Pediatr Radiol. </span>2008;2008;<span class="ref-vol">38</span>:1054–61.</span> [<a href="/pubmed/18636250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18636250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.raval.2015.839">Raval DB, Merideth M, Sloan JL, Braverman NE, Conway RL, Manoli I, Venditti CP. Methylmalonic acidemia (MMA) in pregnancy: a case series and literature review. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015;2015;<span class="ref-vol">38</span>:839–46.</span> [<a href="/pmc/articles/PMC4496322/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4496322</span></a>] [<a href="/pubmed/25567501" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25567501</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.rutsch.2009.234">Rutsch F, Gailus S, Miousse IR, Suormala T, Sagn&#x000e9; C, Toliat MR, N&#x000fc;rnberg G, Wittkampf T, Buers I, Sharifi A, Stucki M, Becker C, Baumgartner M, Robenek H, Marquardt T, H&#x000f6;hne W, Gasnier B, Rosenblatt DS, Fowler B, N&#x000fc;rnberg P. Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism. <span><span class="ref-journal">Nature Genet. </span>2009;<span class="ref-vol">41</span>:234–9.</span> [<a href="/pubmed/19136951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19136951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.ruzkova.2015.807">Ruzkova K, Weingarten TN, Larson KJ, Friedhoff RJ, Gavrilov DK, Sprung J. Anesthesia and organic aciduria: is the use of lactated Ringer's solution absolutely contraindicated? <span><span class="ref-journal">Paediatr Anaesth. </span>2015;<span class="ref-vol">25</span>:807–17.</span> [<a href="/pubmed/25943188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25943188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.sakamoto.2007.48">Sakamoto O, Ohura T, Matsubara Y, Takayanagi M, Tsuchiya S. Mutation and haplotype analyses of the MUT gene in Japanese patients with methylmalonic acidemia. <span><span class="ref-journal">J Hum Genet. </span>2007;<span class="ref-vol">52</span>:48–55.</span> [<a href="/pubmed/17075691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17075691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.saridakis.2004.23646">Saridakis V, Yakunin A, Xu X, Anandakumar P, Pennycooke M, Gu J, Cheung F, Lew JM, Sanishvili R, Joachimiak A, Arrowsmith CH, Christendat D, Edwards AM. The structural basis for methylmalonic aciduria. The crystal structure of archaeal ATP:cobalamin adenosyltransferase. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:23646–53.</span> [<a href="/pubmed/15044458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15044458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.sass.2012.437">Sass JO, Walter M, Shield JP, Atherton AM, Garg U, Scott D, Woods CG, Smith LD. 3-Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenase. <span><span class="ref-journal">J Inherit Metab Dis. </span>2012;<span class="ref-vol">35</span>:437–42.</span> [<a href="/pubmed/21863277" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21863277</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.schwab.2006.107">Schwab MA, Sauer SW, Okun JG, Nijtmans LG, Rodenburg RJ, van den Heuvel LP, Dr&#x000f6;se S, Brandt U, Hoffmann GF, Ter Laak H, K&#x000f6;lker S, Smeitink JA. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. <span><span class="ref-journal">Biochem J. </span>2006;<span class="ref-vol">398</span>:107–12.</span> [<a href="/pmc/articles/PMC1525008/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1525008</span></a>] [<a href="/pubmed/16686602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16686602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.schwartz.2009.629">Schwartz GJ, Mu&#x000f1;oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL. New equations to estimate GFR in children with CKD. <span><span class="ref-journal">J Am Soc Nephrol. </span>2009;<span class="ref-vol">20</span>:629–37.</span> [<a href="/pmc/articles/PMC2653687/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2653687</span></a>] [<a href="/pubmed/19158356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19158356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.s_nac.2012.385">S&#x000e9;nac JS, Chandler RJ, Sysol JR, Li L, Venditti CP. Gene therapy in a murine model of methylmalonic acidemia using rAAV9-mediated gene delivery. <span><span class="ref-journal">Gene Ther. </span>2012;<span class="ref-vol">19</span>:385–91.</span> [<a href="/pmc/articles/PMC3382069/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3382069</span></a>] [<a href="/pubmed/21776024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21776024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.sewell.1996.203">Sewell AC, Poets CF, Degen I, St&#x000f6;ss H, Pontz BF. The spectrum of free neuraminic acid storage disease in childhood: clinical, morphological and biochemical observations in three non-Finnish patients. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">63</span>:203–8.</span> [<a href="/pubmed/8723111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8723111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.shapira.1991.80">Shapira SK, Ledley FD, Rosenblatt DS, Levy HL. Ketoacidotic crisis as a presentation of mild ("benign") methylmalonic acidemia. <span><span class="ref-journal">J Pediatr. </span>1991 Jul;<span class="ref-vol">119</span>(1 Pt 1):80–4.</span> [<a href="/pubmed/2066863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2066863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.shigematsu.2002.39">Shigematsu Y, Hirano S, Hata I, Tanaka Y, Sudo M, Sakura N, Tajima T, Yamaguchi S. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. <span><span class="ref-journal">J Chromatogr B Analyt Technol Biomed Life Sci. </span>2002;<span class="ref-vol">776</span>:39–48.</span> [<a href="/pubmed/12127323" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12127323</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.sloan.2011.883">Sloan JL, Johnston JJ, Manoli I, Chandler RJ, Krause C, Carrillo-Carrasco N, Chandrasekaran SD, Sysol JR, O'Brien K, Hauser NS, Sapp JC, Dorward HM, Huizing M., NIH Intramural Sequencing Center Group.  Barshop BA, Berry SA, James PM, Champaigne NL, de Lonlay P, Valayannopoulos V, Geschwind MD, Gavrilov DK, Nyhan WL, Biesecker LG, Venditti CP. Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:883–6.</span> [<a href="/pmc/articles/PMC3163731/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3163731</span></a>] [<a href="/pubmed/21841779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21841779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.sloan.2015.1346">Sloan JL, Manoli I, Venditti CP. Liver or combined liver-kidney transplantation for patients with isolated methylmalonic acidemia: who and when? <span><span class="ref-journal">J Pediatr. </span>2015;<span class="ref-vol">166</span>:1346–50.</span> [<a href="/pubmed/25882873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25882873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.sniderman.1999.675">Sniderman LC, Lambert M, Giguere R, Auray-Blais C, Lemieux B, Laframboise R, Rosenblatt DS, Treacy EP. Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">134</span>:675–80.</span> [<a href="/pubmed/10356133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10356133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.snyderman.1972.925">Snyderman SE, Sansaricq C, Norton P, Phansalkar SV. The use of neomycin in the treatment of methylmalonic aciduria. <span><span class="ref-journal">Pediatrics. </span>1972 Dec;<span class="ref-vol">50</span>(6):925–7.</span> [<a href="/pubmed/4636459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4636459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.spada.2015.1173">Spada M, Calvo PL, Brunati A, Peruzzi L, Dell'Olio D, Romagnoli R, Porta F. Liver transplantation in severe methylmalonic acidemia: The sooner, the better. <span><span class="ref-journal">J Pediatr. </span>2015;<span class="ref-vol">167</span>:1173.</span> [<a href="/pubmed/26362094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26362094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.stokke.1967.313">Stokke O, Eldjarn L, Norum KR, Steen-Johnsen J, Halvorsen S. Methylmalonic acidemia: a new inborn error of metabolism which may cause fatal acidosis in the neonatal period. <span><span class="ref-journal">Scand J Clin Lab Invest. </span>1967;<span class="ref-vol">20</span>:313–28.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.str_mme.1995.1">Str&#x000f8;mme P, Stokke O, Jellum E, Skjeldal OH, Baumgartner R. Atypical methylmalonic aciduria with progressive encephalopathy, microcephaly and cataract in two siblings--a new recessive syndrome? <span><span class="ref-journal">Clin Genet. </span>1995;<span class="ref-vol">48</span>:1–5.</span> [<a href="/pubmed/7586637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7586637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.stucki.2012.1410">Stucki M, Coelho D, Suormala T, Burda P, Fowler B, Baumgartner MR. Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:1410–8.</span> [<a href="/pubmed/22156578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22156578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.suormala.2004.42742">Suormala T, Baumgartner MR, Coelho D, Zavadakova P, Kozich V, Koch HG, Berghauser M, Wraith JE, Burlina A, Sewell A, Herwig J, Fowler B. The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:42742–9.</span> [<a href="/pubmed/15292234" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15292234</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.therrell.2014.14">Therrell BL Jr, Lloyd-Puryear MA, Camp KM, Mann MY. Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning. <span><span class="ref-journal">Mol Genet Metab. </span>2014;<span class="ref-vol">113</span>:14–26.</span> [<a href="/pmc/articles/PMC4177968/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4177968</span></a>] [<a href="/pubmed/25085281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25085281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.traber.2011.344">Traber G, Baumgartner MR, Schwarz U, Pangalu A, Donath MY, Landau K. Subacute bilateral visual loss in methylmalonic acidemia. <span><span class="ref-journal">J Neuroophthalmol. </span>2011;<span class="ref-vol">31</span>:344–6.</span> [<a href="/pubmed/21873889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21873889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.treacy.1996.445">Treacy E, Arbour L, Chessex P, Graham G, Kasprzak L, Casey K, Bell L, Mamer O, Scriver CR. Glutathione deficiency as a complication of methylmalonic acidemia: response to high doses of ascorbate. <span><span class="ref-journal">J Pediatr. </span>1996;<span class="ref-vol">129</span>:445–8.</span> [<a href="/pubmed/8804337" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8804337</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.tuchman.2008.213">Tuchman M, Caldovic L, Daikhin Y, Horyn O, Nissim I, Nissim I, Korson M, Burton B, Yudkoff M. N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers. <span><span class="ref-journal">Pediatr Res. </span>2008;<span class="ref-vol">64</span>:213–7.</span> [<a href="/pmc/articles/PMC2640836/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2640836</span></a>] [<a href="/pubmed/18414145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18414145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.van_calcar.1998.729">Van Calcar SC, Harding CO, Lyne P, Hogan K, Banerjee R, Sollinger H, Rieselbach RE, Wolff JA. Renal transplantation in a patient with methylmalonic acidaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>1998;<span class="ref-vol">21</span>:729–37.</span> [<a href="/pubmed/9819702" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9819702</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.van_der_meer.1994.903">van der Meer SB, Poggi F, Spada M, Bonnefont JP, Ogier H, Hubert P, Depondt E, Rapoport D, Rabier D, Charpentier C, et al.  Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia. <span><span class="ref-journal">J Pediatr. </span>1994;<span class="ref-vol">125</span>:903–8.</span> [<a href="/pubmed/7996362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7996362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.van_der_meer.1990.923">van der Meer SB, Spaapen LJ, Fowler B, Jakobs C, Kleijer WJ, Wendel U. Prenatal treatment of a patient with vitamin B12-responsive methylmalonic acidemia. <span><span class="ref-journal">J Pediatr. </span>1990;<span class="ref-vol">117</span>:923–6.</span> [<a href="/pubmed/2246694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2246694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.van_t_hoff.1998.1043">van 't Hoff WG, Dixon M, Taylor J, Mistry P, Rolles K, Rees L, Leonard JV. Combined liver-kidney transplantation in methylmalonic acidemia. <span><span class="ref-journal">J Pediatr. </span>1998;<span class="ref-vol">132</span>:1043–4.</span> [<a href="/pubmed/9627602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9627602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.vant_hoff.1999.s70">van't Hoff W, McKiernan PJ, Surtees RA, Leonard JV. Liver transplantation for methylmalonic acidaemia. <span><span class="ref-journal">Eur J Pediatr. </span>1999;<span class="ref-vol">158</span> Suppl 2:S70–4.</span> [<a href="/pubmed/10603103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10603103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.vernon.2014.899">Vernon HJ, Sperati CJ, King JD, Poretti A, Miller NR, Sloan JL, Cameron AM, Myers D, Venditti CP, Valle D. A detailed analysis of methylmalonic acid kinetics during hemodialysis and after combined liver/kidney transplantation in a patient with mut (0) methylmalonic acidemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>2014;<span class="ref-vol">37</span>:899–907.</span> [<a href="/pmc/articles/PMC4373418/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4373418</span></a>] [<a href="/pubmed/24961826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24961826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.walter.1989.344">Walter JH, Michalski A, Wilson WM, Leonard JV, Barratt TM, Dillon MJ. Chronic renal failure in methylmalonic acidaemia. <span><span class="ref-journal">Eur J Pediatr. </span>1989;<span class="ref-vol">148</span>:344–8.</span> [<a href="/pubmed/2707280" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2707280</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.wasserstein.1999.788">Wasserstein MP, Gaddipati S, Snyderman SE, Eddleman K, Desnick RJ, Sansaricq C. Successful pregnancy in severe methylmalonic acidaemia. <span><span class="ref-journal">J Inherit Metab Dis. </span>1999;<span class="ref-vol">22</span>:788–94.</span> [<a href="/pubmed/10518278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10518278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.williams.2009.929">Williams ZR, Hurley PE, Altiparmak UE, Feldon SE, Arnold GL, Eggenberger E, Mejico LJ. Late onset optic neuropathy in methylmalonic and propionic acidemia. <span><span class="ref-journal">Am J Ophthalmol. </span>2009;<span class="ref-vol">147</span>:929–33.</span> [<a href="/pubmed/19243738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19243738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.wong.1992.180">Wong SN, Low LC, Lau YL, Nicholls J, Chan MY. Immunodeficiency in methylmalonic acidaemia. <span><span class="ref-journal">J Paediatr Child Health. </span>1992;<span class="ref-vol">28</span>:180–3.</span> [<a href="/pubmed/1562372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1562372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.worgan.2006.31">Worgan LC, Niles K, Tirone JC, Hofmann A, Verner A, Sammak A, Kucic T, Lepage P, Rosenblatt DS. Spectrum of mutations in mut methylmalonic academia and identification of a common Hispanic mutation and haplotype. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:31–43.</span> [<a href="/pubmed/16281286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16281286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.yang.2004.329">Yang X, Sakamoto O, Matsubara Y, Kure S, Suzuki Y, Aoki Y, Suzuki Y, Sakura N, Takayanagi M, Iinuma K, Ohura T. Mutation analysis of the MMAA and MMAB genes in Japanese patients with vitamin B(12)-responsive methylmalonic acidemia: identification of a prevalent MMAA mutation. <span><span class="ref-journal">Mol Genet Metab. </span>2004;<span class="ref-vol">82</span>:329–33.</span> [<a href="/pubmed/15308131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15308131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.yano.2003.481">Yano S, Li L, Le TP, Moseley K, Guedalia A, Lee J, Gonzalez I, Boles RG. Infantile mitochondrial DNA depletion syndrome associated with methylmalonic aciduria and 3-methylcrotonyl-CoA and propionyl-CoA carboxylase deficiencies in two unrelated patients: a new phenotype of mtDNA depletion syndrome. <span><span class="ref-journal">J Inherit Metab Dis. </span>2003;<span class="ref-vol">26</span>:481–8.</span> [<a href="/pubmed/14518828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14518828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.yu.2013.506">Yu HC, Sloan JL, Scharer G, Brebner A, Quintana AM, Achilly NP, Manoli I, Coughlin CR 2nd, Geiger EA, Schneck U, Watkins D, Suormala T, Van Hove JL, Fowler B, Baumgartner MR, Rosenblatt DS, Venditti CP, Shaikh TH. An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">93</span>:506–14.</span> [<a href="/pmc/articles/PMC3769968/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3769968</span></a>] [<a href="/pubmed/24011988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24011988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.zsengell_r.2014.2139">Zsengell&#x000e9;r ZK, Aljinovic N, Teot LA, Korson M, Rodig N, Sloan JL, Venditti CP, Berry GT, Rosen S. Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney. <span><span class="ref-journal">Pediatr Nephrol. </span>2014;<span class="ref-vol">29</span>:2139–46.</span> [<a href="/pubmed/24865477" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24865477</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mma.REF.zwickler.2012.797">Zwickler T, Haege G, Riderer A, H&#x000f6;rster F, Hoffmann GF, Burgard P, K&#x000f6;lker S. Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative? <span><span class="ref-journal">J Inherit Metab Dis. </span>2012;<span class="ref-vol">35</span>:797–806.</span> [<a href="/pubmed/22249333" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22249333</span></a>]</div></li></ul></div></div><div id="mma.Chapter_Notes"><h2 id="_mma_Chapter_Notes_">Chapter Notes</h2><div id="mma.Author_Notes"><h3>Author Notes</h3><p>Dr Manoli is a pediatrician and clinical and biochemical geneticist. She is a staff clinician at the Organic Acid Research Unit of the National Human Genome Research Institute, at the National Institutes of Health.</p><p>Dr Venditti is a pediatrician and clinical and biochemical geneticist. He is the director of the Organic Acid Disorder Research Unit at the National Human Genome Research Institute and an attending physician at the National Institutes of Health Clinical Center.</p></div><div id="mma.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 December 2016 (cpv) Revision: Molecular Genetics: <i>MMAB</i> and <i>MMUT</i></div></li><li class="half_rhythm"><div>7 January 2016 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 September 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 January 2007 (cd) Revision: testing for mutations in <i>MMAA</i> and <i>MMAB</i> clinically available</div></li><li class="half_rhythm"><div>16 August 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>11 May 2004 (cpv) Original submission</div></li></ul><p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <i>GeneReview</i> "Isolated Methylmalonic Acidemia" is in the public <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the United States of America.</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1231</span><span class="label">PMID: <a href="/pubmed/20301409" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301409</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kms/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/iso-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1231&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1231/?report=reader">PubReader</a></li><li><a href="/books/NBK1231/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1231" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1231" style="display:none" title="Cite this Page"><div class="bk_tt">Manoli I, Sloan JL, Venditti CP. Isolated Methylmalonic Acidemia. 2005 Aug 16 [Updated 2016 Dec 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1231/pdf/Bookshelf_NBK1231.pdf">PDF version of this page</a> (901K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mma.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mma.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#mma.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#mma.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#mma.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#mma.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#mma.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mma.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mma.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mma.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#mma.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mma.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84693[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MCEE</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4594[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MMUT</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=326625[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MMAB</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=166785[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MMAA</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=27249[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MMADHC</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1486158" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1486158" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1486158" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1486158" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301503" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sloan JL, Carrillo N, Adams D, Venditti CP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24095221" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Renal involvement in a patient with cobalamin A type (cblA) methylmalonic aciduria: a 42-year follow-up.</a><span class="source">[Mol Genet Metab. 2013]</span><div class="brieflinkpop offscreen_noflow">Renal involvement in a patient with cobalamin A type (cblA) methylmalonic aciduria: a 42-year follow-up.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Haarmann A, Mayr M, Kölker S, Baumgartner ER, Schnierda J, Hopfer H, Devuyst O, Baumgartner MR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2013 Dec; 110(4):472-6. Epub 2013 Sep 17.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29996803" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mild clinical features of isolated methylmalonic acidemia associated with a novel variant in the MMAA gene in two Chinese siblings.</a><span class="source">[BMC Med Genet. 2018]</span><div class="brieflinkpop offscreen_noflow">Mild clinical features of isolated methylmalonic acidemia associated with a novel variant in the MMAA gene in two Chinese siblings.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lin Y, Lin C, Lin W, Zheng Z, Han M, Fu Q. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Med Genet. 2018 Jul 11; 19(1):114. Epub 2018 Jul 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31536184" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glutaric Acidemia Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glutaric Acidemia Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Larson A, Goodman S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301409" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301409" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040cab39a66ee2ba4d92c6">Isolated Methylmalonic Acidemia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Isolated Methylmalonic Acidemia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:28:12-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88F16AE03FE8E100000000058E01C4&amp;ncbi_session=CE88F16AE040CAB1_1422SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1231%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1231&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1231/&amp;ncbi_pagename=Isolated Methylmalonic Acidemia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88F16AE040CAB1_1422SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>